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The Blind Men and the Elephant
(John Godfrey Saxe, 1816-1887, based on an Indian fable)
It was six men of Indostan                The Fifth, who chanced to touch the ear,
To learning much inclined,     Said: “E`en the blindest man
Who went to see the Elephant                  Can tell what this resembles most;
(Though all of them were blind),     Deny the fact who can
That each by observation                          This marvel of an Elephant
Might satisfy his mind     Is very like a fan!”
The First approached the Elephant  The Sixth no sooner had begun
And happening to fall     About the beast to grope,
Against his broad and sturdy side,  Then, seizing on the swinging tail
At once began to bawl:     That fell within his scope,
“God bless me! but the Elephant  “I see,” quoth he, “the Elephant
Is very like a wall!”      Is very like a rope!”
The Second, feeling of the tusk,   And so these men of Indostan
Cried, “Ho! what have we here      Disputed loud and long,
So very round and smooth and sharp?   Each in his own opinion
To me `tis mighty clear      Exceeding stiff and strong,
This wonder of an Elephant   Though each was partly right,
Is very like a spear!”      And all were in the wrong!
The Third approached the animal,
And happening to take
The squirming trunk within his hands,
Thus boldly up and spake:
“I see,” quoth he, “the Elephant
Is very like a snake!”     Moral:
The Fourth reached out an eager hand,     So oft in these scientific wars,
And felt about the knee.   The disputants, I ween,
“What most this wondrous beast is like     Rail on in utter ignorance
Is mighty plain,” quoth he;    Of what each other mean,
`Tis clear enough the Elephant     And prate about an Elephant
Is very like a tree!”   Not one of them has seen!
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1     Introduction
1.1   Innate and adaptive immunity
In vertebrates different levels of adaptive immune reactions including T-cell responses
and antibody production have evolved, leading to a highly adaptive defence system
against microorganisms. Mammals can acquire immunity to pathogens during their
individual life span, for example by memory cells for specific antibodies. However, the
initial induction of an adaptive response takes several days, which is generally not
sufficient for the survival of the organism. In addition many pathogens have evolved
mechanisms to evade or destroy the host defence response. Therefore components of the
vertebrate innate immune system, such as antimicrobial peptides and phagocytosing
macrophages, are crucial during the first contact with a pathogen. Even all invertebrates
including the phylogenetic ancient sponges possess innate immune responses.
1.2   Model organisms used in this study
Insects and other invertebrates rely exclusively on innate immunity. Hence they are
promising model organisms for the investigation of this subject. The recently increasing
number of studies on immune functions of Toll-like receptors in vertebrates was
initiated and stimulated by insights from the insect defence system. Insects are also of
high economical and medical importance. Some species are beneficial (like the
honey-bee Apis mellifera), others are noxious (for example the diamondback moth
Plutella xylostella) for economically important plants. Insect vectors transmit animal
and human diseases like malaria or yellow fever and spread plant pathogens. Since
insecticides often have hazardous side effects for the environment and because insects
can evolve resistance mechanisms fairly quick, it may be a promising insect pest
management strategy to interfere with novel targets of the insect immune system.
In our research project we use two insect species, the dipteran Drosophila melanogaster
and the lepidopteran Galleria mellonella. D. melanogaster has been successfully
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investigated for a long time, partly because it is easy to cultivate. Well-established
genetics and the fully sequenced genome provide a good basis for molecular research.
In addition Drosophila has been in the focus of insect immunity during the last decade.
Nevertheless, there are limitations to using Drosophila as a model system.
Evolutionary, D. melanogaster and other dipterans represent a rather derived insect
order (Burmester et al., 1998). Newly found immune proteins could be specific for
Drosophila and lacking in other insects. At the same time, it is precisely these species-
specific traits that may provide new insights into the adaptation of an immune system to
a particular environment. For example, larvae of D. melanogaster live in rotten fruit
rich in bacteria, which might necessitate stronger immune responses than in other
insects. Furthermore the observed variety between insect immune systems is probably
partly due to size differences and variable haemolymph amounts. The latter might be an
important, but so far not investigated issue regarding haemolymph clotting.
Therefore I decided to also study the lepidopteran Galleria mellonella (greater wax
moth). Morphological changes during coagulation in G. mellonella have been examined
for a long time. The hundred times larger haemolymph amount of this species
(approximately 50 ml versus 0,5 ml per individual in Drosophila) also facilitates quick
pilot experiments.
1.3   Haemocyte types in G. mellonella and D. melanogaster
The body fluid of insects and other animals with an open circulatory system is called
“haemolymph” to stress the fact that there is no separation between blood and the
lymphatic fluid as in vertebrates. Similarly the cells circulating in the haemolymph are
termed “haemocytes”. In insects these cells facilitate cellular immune reactions such as
phagocytosis, nodulation and encapsulation (Ratcliffe & Rowley, 1979, Lackie, 1988,
Lavine & Strand, 2002), which will be summarised in the following chapter. Moreover
in many insects specific tasks can be exclusively assigned to certain haemocyte types
with distinct morphological appearance. Recognition of a defined haemocyte class by a
lectin or antiserum can substantially support functional data obtained with this labelling
agent. The haemocyte classes present in insects differ between orders and even between
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rather related species. Therefore I present here the haemocyte types of the two species
investigated in the present work.
In lepidopterans like G. mellonella the main haemocyte types found in haemolymph
preparations are plasmatocytes and granular cells (Chain & Anderson, 1983). In
addition prohaemocytes, oenocytoids and spherule cells have been described.
Prohaemocytes belong to a homogenous group of small progenitor cells of the other
haemocyte types. Plasmatocytes can form large pseudopodia and possess the ability to
attach to and spread on surfaces. They can form multicellular capsules around larger
pathogens, which cannot be phagocytosed. Both granular cells and plasmatocytes of
G. mellonella show phagocytic activity (Tojo et al., 2000). The cytoplasm of granular
cells is filled with large numbers of granular inclusions, whose contents can be released
into the medium upon activation. In contrast to plasmatocytes granular cells do not
spread extensively, but can also adhere to surfaces via microspikes and mucous fibres of
degranulated intracellular material (Chain & Anderson, 1983). This degranulation
process may be crucial for the initiation of coagulation, nodule formation and
encapsulation (Rowley & Ratcliffe, 1976, 1978). Oenocytoids are sites of
prophenoloxidase production. Earlier descriptions of prophenoloxidase localisation in
granular cells (Ratcliffe, 1984) can be explained by melanin deposition around granular
cells (Ashida & Yamazaki, 1992). The function of spherule cells is not yet clear. These
cells contain large amounts of mucopolysaccharides and were therefore suggested to
contribute to extracellular matrix (ECM) formation in other insect species (Ashhurst,
1982, Horohov & Dunn, 1982). The construction of a basal lamina is required for
successful wound healing and thus may be connected to the coagulation process.
The haemocyte classes described for D. melanogaster differ from the ones of
G. mellonella considerably. Three haemocyte types can be distinguished in Drosophila:
plasmatocytes, crystal cells and lamellocytes (Lanot et al., 2001). The podocyte, a
fourth set of cells described in earlier studies (Rizki, 1957), is probably derived from
plasmatocytes. Plasmatocytes do not spread as extensively as their lepidopteran
counterparts and are mostly phagocytic active. While no granular cells are present in
Drosophila, a subgroup of plasmatocytes containing numerous granules might fulfil
similar functions. Crystal cells contain regular-shaped inclusions, which dissolve
quickly as soon as these haemocytes disintegrate upon activation (Rizki & Rizki, 1985).
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Through this cell rupture the enzyme prophenoloxidase and its tyrosine substrates,
which are spatially separated inside the crystal cells, come into close contact in the
haemolymph, leading to a localised enzymatic activity. Haemocytes isolated from
Drosophila larvae are largely derived from the embryonic head mesoderm. Only
towards the end of the third larval instar larval haemocytes are released from the larval
haematopoietic organ (Holz et al., 2003). Differentiation of haemocyte precursor cells
into lamellocytes in the lobes of the hematopoietic organ is induced by parasitoid
infections in Drosophila (Lanot et al., 2001). Lamellocyte numbers also increase in the
last larval instar towards pupation (personal observation).
Since similar cellular immune reactions occur in all insects, it may be assumed that
there are some poorly understood molecular similarities between haemocyte types of
different species and orders of insects. For example, the already described involvement
of Galleria granular cells in haemolymph coagulation probably has its counterpart in
Drosophila plasmatocytes or in a plasmatocyte subclass yet to be identified.
1.4   The insect immune system
Innate immunity in insects is conventionally divided into cellular and humoral
responses (Gillespie et al., 1997, Vilmos & Kurucz, 1998). Phagocytosis, nodulation
and encapsulation are summarised as cellular immune reactions. Coagulation,
melanisation and induction of antimicrobial peptides are regarded as humoral defence
reactions. However, this separation may be considered artificial, since many
haemolymph proteins are originally released from haemocytes and others are directly
connected to cellular immunity. Processes like clotting and wound healing might
involve both cellular and humoral components. Hence, I will present the main aspects of
an immune response in a temporal order (Figure 1). Because of the rapidity of events,
mutants defective in clotting might not survive wounding, even if other aspects of the
immune system are not directly affected. Moreover, it should be noted that most
defence responses require a recognition mechanism that might be provided by the
coagulum and the entrapped microorganisms at the wound site. In this chapter I will
highlight the reactions that are probably closely related to coagulation, namely
melanisation, encapsulation and wound healing.
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Figure 1: Insect immunity – an overview
              This is a schematic summary of insect immune responses, emphasising the
time element. Later wound healing events are not included in the picture.
    aPL: anionic phospholipids; RGD: arginine-glycine-asparagine
1.4.1   Cuticle and peritrophic membrane – the first line of defence
Microorganisms are ubiquitously present in large numbers in practically every
environment and are potentially harmful to all organisms. In insects the hard chitinous
exocuticle provides a first mechanical barrier for microorganisms, covering even the
tracheal openings, fore- and hindgut. The midgut surface secretes a peritrophic
membrane that mainly consists of glycoproteins and chitinous fibrils. One proposed
function of peritrophic matrices is to prevent microorganisms in the ingested food from
entering the haemocoele (Orihel, 1975). Digestive enzymes and the low pH in the gut
create a hostile environment for many microbes. In addition, constitutively secreted
antimicrobial proteins like lysozyme (Hultmark, 1996) may assist in quick killing of
microorganisms. Some pathogens are able to penetrate the cuticle, especially at the thin
synovial membranes. Wounds are even more vulnerable to intrusion by microorganisms.
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1.4.2   Coagulation and phagocytosis – immediate immune reactions
Haemolymph coagulation fulfils at least two functions: it quickly seals wounds to avoid
haemolymph loss and to prevent pathogens from entering the body cavity. Compared to
vertebrate blood clotting pathogen, immobilisation might be a more critical issue in the
open circulatory system of insects, because pathogens may easily spread to the inner
organs and invade them. Simultaneously the danger of thrombosis is presumably lower
in arthropods, allowing an extensive coagulation reaction without harmful consequences
for the organism (Theopold et al., 2004). Morphological changes during clotting and
biochemical characterisation of the involved proteins in vertebrates and invertebrates
will be discussed in detail in chapter 1.5.
Two insect haemocyte subtypes, granular cells and plasmatocytes, phagocytose bacteria
(Lackie, 1988). Interestingly, the presence of granular cells increases phagocytotic
activity of plasmatocytes in G. mellonella (Anggraeni & Ratcliffe, 1991). It has been
suggested that granular cells exocytose substances that facilitate phagocytosis, probably
by opsonisation of the pathogens. Phagocytosis in the medfly Ceratitis capitata for
example involves recognition of RGD-peptides by cell membrane integrins (Foukas et
al., 1998). The RGD motif and other molecules of haemocyte origin were also implied
earlier in stimulation of encapsulation (see chapter 1.4.4). Deposition of substances on
pathogen surfaces by degranulating haemocytes during clotting might thus activate
phagocytosis and other cellular immune responses.
Like vertebrate macrophages, insect haemocytes also produce reactive oxygen and
nitrogen intermediates (ROI and RNI) that effectively kill microorganisms (Nappi &
Ottaviani, 2000). This direct killing is possibly important for the clearance of pathogens
that have become immobilised at the wound site by haemolymph clotting.
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1.4.3   Melanisation – immobilisation and killing of pathogens
Melanisation fulfils multiple functions like sclerotisation, egg shell tanning and
immunity. Melanin formation is catalysed by phenoloxidases, which belong to a protein
family present in plants, fungi and animals including invertebrates and vertebrates.
These enzymes are divided into three classes with overlapping substrate specificities:
monophenoloxidases/tyrosinases, o-diphenoloxidases and p-diphenoloxidases/laccases
(Sugumaran & Kanost, 1993). In horseshoe crabs and crustaceans the oxygen-
transporting hemocyanins possess an intrinsic phenoloxidase activity (Decker et al.,
2001, Nagai et al., 2001). Interestingly, hemocyanin activation is connected to initiation
of the horseshoe crab clotting cascade (Nagai & Kawabata, 2000). Insects possibly
evolved specialised phenoloxidases from an ancient hemocyanin precursor, primarily to
sclerotise and harden the cuticle (Sugumaran, 1988). The cuticular prophenoloxidase of
Bombyx mori is derived from the haemolymph enzyme by modification during its
transport into the cuticle (Asano & Ashida, 2001a, 2001b). Haemolymph
phenoloxidases are present as pro-forms (prophenoloxidases), which are activated by a
protease cascade and regulated by serine protease inhibitors, serpins (Cerenius &
Söderhäll, 2004). In addition to proteolytic induction after bacterial challenge (Ashida
& Yamazaki, 1990) an alternative regulation pathway involving phospholipids from
damaged cells (Sugumaran & Nellaiappan, 1991, Sugumaran & Kanost, 1993) has been
described, which will be discussed in chapter 1.8. Activated phenoloxidases form
quinones from phenolic substrates present in the haemolymph. Subsequently these
products oligomerise, culminating in melanin deposition on surfaces. The hardening
effect of quinones is commonly assigned to polymerisation, though some researchers
regarded a dehydration effect of quinones as even more important (Vincent, 1990).
Besides facilitating melanin formation, the intermediate quinone products are highly
cytotoxic substances that might directly kill microorganisms immobilised in the
coagulum. Several research groups in insect immunity suggested that phenoloxidases
may represent the exclusive clotting- and wound healing-enzyme in insects. This idea is
based on the observation that melanin is deposited in capsules around pathogens (Gupta,
1988) and at sites of injuries (Lai-Fook, 1966). Nevertheless, it was also reported that
encapsulation even occurs in Drosophila phenoloxidase mutants like Black cells (Rizki
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& Rizki, 1990) or after inhibition of the enzyme (Lavine & Strand, 2001). In a detailed
study of wound healing in the mosquito Armigeres subalbatus it was shown that a
gelatinous clot formed much earlier than melanisation became visible (Lai et al., 2002).
This observation was recently confirmed for Drosophila wound healing (Galko &
Krasnow, 2004). When I started the present work, it was therefore hypothesised that the
initial clotting reaction might be independent of phenoloxidase activity.
1.4.4   Nodulation, encapsulation and wound healing –
           stabilising the scene
Large amounts of bacteria that cannot be phagocytosed, are enclosed in multicellular
nodules. Bigger organisms like protozoans and eggs of parasitoid wasps are
encapsulated. Both nodules and capsules are formed by haemocytes and have been
predominantly studied in lepidopteran insects. Encapsulation occurs in a regulated
manner in many lepidopterans (Ratcliffe & Gagen, 1977, Ratcliffe, 1986), though the
location of haemocyte types in the capsule appears random in some species (Wiegand et
al., 2000). According to the classical model suggested by Ratcliffe & Rowley (1979)
haemocytes of the granular cell type, start to disintegrate on microorganism surfaces
and exocytose molecules that form an extracellular aggregate. Among the released
substances the “plasmatocyte spreading factor” may induce haemocyte chemotaxis
(Clark et al., 1997) and thereby launch the second phase of capsule construction:
Plasmatocytes are attracted, spread and flatten around the first layer formed by granular
cells (Strand & Clark, 1999). RGD-containing proteins present in the degranulated
material mediate plasmatocyte adhesion (Pech & Strand 1995, 1996). Though granular
cells are missing in D. melanogaster, several plasmatocytes include numerous granules
and thus may fulfil similar immune functions in the fly. However, to date only
Drosophila lamellocytes are known to participate in capsule formation (Rizki & Rizki,
1986). It is interesting to note that in some dipterans with low haemocyte counts a so-
called humoral encapsulation proceeds in the absence of cells (Götz, 1986). These
“humoral capsules” might well correspond to what I call a haemolymph clot or
coagulum throughout the present investigation. The first steps of nodulation and
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encapsulation have repeatedly been characterised as morphologically similar to
haemolymph coagulation (Bohn, 1986, Ratcliffe, 1986). Nodulation is even induced in
the absence of microbial agents by saline injection in cockroaches and locusts
(Gunnarsson & Lackie, 1985). This suggests an alternative pathogen-independent
mechanism of haemocyte activation, which might be identical with clotting or induced
by agents such as phospholipids released from or exposed on wounded cells (see
chapter 1.8). Although capsules often become melanised, active phenoloxidase is not
essentially required for encapsulation in D. melanogaster (Rizki & Rizki, 1990).
Haemolymph coagulation has long been recognised as the first phase of wound healing
(Rowley & Ratcliffe, 1978). Primary plug formation is followed by melanisation of the
scab and epidermal spreading reactions. Recently the mentioned steps in wound healing
have been investigated in Drosophila (Galko & Krasnow, 2004). Analysing mutants of
the phenoloxidase regulation, these authors concluded that melanisation is crucial for
survival of the wounded animal by strengthening the wound plug. Yet the subsequent
epidermal spreading reactions stimulated by the JNK pathway were stated to be
independent of phenoloxidase activity. Epithelial cells orient towards the wound, fuse
with each other and finally spread over the scab. These epithelial cell movements
resemble dorsal closure during Drosophila embryogenesis (Wood et al., 2002), which is
regulated by the Jun N-terminal kinase (JNK) signalling pathway as well (Rämet et al.,
2002). The temporal order of the different phases of wound closure was studied in the
mosquito Armigeres subalbatus (Lai et al., 2002). The authors of this study reported the
establishment of a haemocyte plug already one minute after injury. Cells in this clump
quickly released granular material that aggregated to an insoluble coagulum. Hardening
of the primary clot by melanisation was observed after two hours. Flattening
plasmatocytes or Drosophila lamellocytes might participate in the first cellular layer
covering the wound as well, maybe adhering through RGD-dependent interactions, as
proposed by Lackie (1988).
As the epidermal spreading and fusion reactions reach their end, a new basal membrane
has to be synthesised around injuries or capsules to inhibit further haemocyte
attachment. In Pseudoplusia includens apoptotic granular cells form a final layer at
capsule peripheries (Pech & Strand, 1996, 2000). It remains to be investigated, if new
basement membranes at wounds are produced by haemocytes or by epidermal cells.
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1.4.5   Induction of antimicrobial peptides
Antimicrobial peptides are ubiquitously present in both prokaryotes and eukaryotes
(Bulet et al., 2004). They are divided into several chemical classes and most of them act
on microbial membranes through interaction with bacterial lipids (Bulet et al., 1999).
The major amount of antimicrobial peptides in the haemolymph of insects is
transcriptionally regulated after infection (Uttenweiler-Joseph et al., 1998, Engström,
1999) and they appear in the haemolymph after approximately two to four hours
(Meister et al., 1997). Incorporation of these bioactive peptides in a haemolymph clot
might promote killing of the entrapped microorganisms (not shown in Figure 1).
Antimicrobial peptide induction in D. melanogaster shows limited specificity for certain
microorganism groups, namely fungi, Gram-positive and Gram-negative bacteria.
Interestingly, the intracellular signalling pathways regulating Drosophila antimicrobial
peptide genes share similarities with mammalian immune induction mechanisms
(Hultmark, 2003). However, in difference to mammals Drosophila antimicrobial genes
are regulated by two distinct cascades, the Toll and the Imd pathway (Hoffmann, 2003).
Pattern recognition molecules on the pathogen surfaces are bound by peptidoglycan
recognition proteins (PGRPs) which transmit the signal for peptide gene induction. In
Gram-positive bacteria, Lys-type peptidoglycan is recognised by PGRP-SA in the
haemolymph that activates the Toll pathway. The membrane-bound PGRP-LCx is
specific for DAP-type peptidoglycan of Gram-negative bacteria and directly stimulates
the Imd molecule, possibly as a heterodimer with PGRP-LCa (Steiner, 2004). Mammals
widely rely on recognition of lipopolysaccharides (LPS). However, recent results
suggest that the LPS molecule has no effect on the induction of antimicrobial peptide
genes in Drosophila (Kaneko et al., 2004). Nevertheless, lipopolysaccharides are potent
activator of the melanisation cascade in insects and may stimulate other immune
reactions as well.
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1.4.6   Towards an integrated view of coagulation in innate immunity
Haemolymph coagulation is one of the immediate reactions occurring after wounding.
Since natural infections may occur through wounds, it is also likely that clotting is
linked to immune processes. For example nodulation does not necessarily require the
presence of bacteria (Gunnarsson & Lackie, 1985) and might thus be directly stimulated
by primary wound reactions like coagulation. Furthermore it is possible that the immune
response is directed by clotting, either towards a more cellular (nodulation,
encapsulation) or towards a predominantly humoral reaction (melanisation,
antimicrobial peptides). Regardless of potential regulatory functions, coagulation
facilitates a localised immune response by immobilising and concentrating
microorganisms at the site of injury. This may include local generation of cytotoxic
phenoloxidase products by disintegrating cells in the coagulum and direction of
antimicrobial activity to wound sites. Mutations with an affected nodulation,
encapsulation or melanisation response may initially be caused by coagulation defects
and should thus be re-investigated carefully. In summary, haemolymph clotting is
clearly underrepresented in the current picture of insect immunity.
De novo induction of genes for clot proteins is probably too slow for efficient and quick
wound sealing. These factors are rather expected to be constitutively present in the
haemolymph or quickly released from activated haemocytes. Data available from
Drosophila immune microarrays hence only provide limited information regarding
possible clotting components, although replenishment of lowered haemolymph protein
levels after coagulation might lead to a late gene induction pattern.
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1.5   Comparison of coagulation in vertebrates and arthropods
1.5.1 Vertebrate blood clotting – primary and secondary haemostasis
Coagulation is “the change from a liquid to a thickened […] state (lat: coagulatio), not
by evaporation, but by some kind of chemical reaction” (Webster`s dictionary, 1913).
Clotting has historically long been regarded as a process separate from the immune
response. Only recently it was suggested that coagulation and innate immunity evolved
from a common ancestral immune system and continue to interact and cooperate with
each other (Opal & Esmon, 2003). Localised coagulation not only enables wound
closure, but also immobilises bacteria along with damaged cells and triggers
inflammation. In vertebrates blood clotting is subdivided into primary and secondary
reactions (Clemetson, 1999). During primary haemostasis aggregating platelets form a
plug at the wound site (Figure 2). The scab is subsequently stabilised by fibrin
polymerisation resulting from an activated clotting cascade (secondary haemostasis).
Later the platelets retract to the edges of the lesion, followed by final spreading of
endothelial cells over the injury. In the initial response von Willebrand factor (vWF)
binds to collagen exposed on wounded subendothelium. A conformational change in
vWF occurs after attachment, rendering it accessible to binding of the platelet
membrane glycoprotein GPIb and thereby stimulates cell adhesion to the
subendothelium (Sadler, 1998). Consequently, the platelet cytoskeleton is activated and
the cells start to release further clot components through degranulation (Clemetson,
1999). In von Willebrand disease (VWD), characterised by mutated or absent vWF,
primary haemostasis is impaired, which causes prolonged bleeding times (Sadler, 1998,
Triplett, 2000). The von Willebrand factor also interacts with factor VIII, a component
of the serine protease cascade (Jorieux et al., 2000).
This proteolytic cascade is regulated by two distinct pathways, an extravascular
(extrinsic) and an intravascular (intrinsic) system. The extrinsic route is induced by the
release of the intracellular tissue factor from ruptured cells at the wound site. In contrast
the intrinsic system is stimulated by negatively charged surfaces, especially collagen
exposed on damaged cell membranes of blood vessel walls. The two regulatory
pathways combine to a common cascade initiated by clotting factor X. In addition to the
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proteolytic activation, several factors require calcium and negatively charged
phospholipids released from platelets as cofactors. The latter will be discussed in more
detail later (see chapter 1.8). In the final step of the clotting cascade a transglutaminase,
also known as factor XIII, cross-links lysine and glutamine residues of activated fibrin
molecules with each other, thus hardening the clot. In addition vWF, fibronectin and
other factors with high molecular weight are covalently linked to fibrin by factor XIII
(Corbett et al., 1997). Many of the mentioned proteins like vWF, fibrinogen, fibronectin
and endothelial collagen include the amino acid sequence RGD (Figure 2), which
facilitates further integrin-mediated attachment of blood cells and links them together to
stabilise the wound. As mentioned earlier, the RGD motif plays a crucial role in
stimulation of cellular immune reactions in insects as well.
Figure 2: Vertebrate blood clotting: primary haemostasis
                 (modified after Clemetson, 1999)
1.5.2   The coagulation cascade of horseshoe crabs
Horseshoe crabs are the invertebrates, in which haemolymph coagulation has been
studied most extensively. Clotting is activated by bacteria and more specifically by
minute amounts of beta-glucan or lipopolysaccharide (Figure 3). This property of
horseshoe crab haemolymph has been used since long as a quick clinical test for the
- integrins -
(RGD)
(RGD)
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presence of LPS in patients (Nakamura et al., 1977). Activation of the clotting system
by LPS was recently shown to be dependent on regulation by an NFkB motif (Wang et
al., 2003), a promoter sequence that is also important for the regulation of several
antibacterial peptide genes (Engström, 1999). Bacteria (Isakova & Armstrong, 2003)
and immune proteins (Armstrong & Armstrong, 2003) are entrapped in the horseshoe
crab coagulum, reflecting a protective function of the clot besides its haemostatic role.
All elements of the proteolytic clotting cascade as well as regulating protease inhibitors
are stored in haemocyte granules and released upon stimulation (Muta & Iwanaga,
1996, Iwanaga & Kawabata, 1998). Among the components of the horseshoe crab
coagulation system there is only one orthologue to vertebrate clotting factors, namely
transglutaminase, which is released from haemocytes into the plasma. An involvement
of transglutaminase in coagulation was doubted for long, since another specific
“clotting enzyme” proteolytically activates the haemolymph coagulogen (Figure 3).
Recently it was reported, that primary coagulin aggregates are consequently cross-
linked to residues on haemocyte membranes by transglutaminase (Osaki et al., 2002,
Osaki & Kawabata, 2004).
Figure 3: The haemolymph clotting system of the horseshoe crab
     (changed after Muta & Iwanaga, 1996)
crosslinking by
transglutaminase
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1.5.3   Haemolymph clotting in crustaceans
Like in other arthropods coagulation in crustaceans consists of two main steps, the
degranulation of aggregating granular cells and subsequent formation of gelatinous
material in the haemolymph (Ravindranath, 1980). The cross-linking enzyme
transglutaminase is released from blood cells (“haemocyte coagulogen”), while the
clottable protein is constitutively present in the haemolymph (“plasma coagulogen”). In
contrast to horseshoe crabs and vertebrates, no proteolytic cascade seems to be involved
in the activation process. However, coagulation essentially requires calcium as a
transglutaminase cofactor and to initiate haemocyte degranulation (Hall et al., 1999).
The clotting protein in crustaceans was isolated from several species and characterised
as a large lipoprotein related to insect vitellogenins (Fuller & Doolittle, 1971a, Komatsu
& Andó, 1998, Yeh et al., 1999). In comparison to vitellogenins the clotting protein
contains additional lysine- and glutamine-rich domains, which are targets for cross-
linking by transglutaminase (Fuller & Doolittle, 1971b, Hall et al., 1999). It was
proposed, that the crustacean prophenoloxidase system might act as a positive feedback
mechanism by stimulating the release of transglutaminase and other clotting
components from haemocytes (Hall et al., 1999). However, it may alternatively be the
initial coagulation process that activates the prophenoloxidase cascade.
1.5.4   Insect haemolymph coagulation
Many morphological and cell-biological studies have been performed on insect
haemolymph coagulation (Bohn, 1986). In contrast, only a limited amount of
biochemical data is available on the molecular identity of factors involved in insect
clotting (Theopold et al., 2002). Different requirements of vertebrate and invertebrate
clotting systems due to certain characteristics of their physiology have been reviewed
recently (Theopold et al., 2004).
Coagulation has to be activated quickly and regulated strictly. Constitutive presence of
plasma factors might facilitate an almost immediate reaction, while proteins released
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from haemocytes may help to avoid a premature activation of haemolymph clotting and
to ensure a localised response. The initiation process probably involves oxygen
originating from the air contact at the wound site. Under experimental conditions
coagulation mostly occurs at the edges of cover slips covering haemolymph samples on
slides and is slowed down by quick specimen preparation limiting oxygen access (Bohn,
1986 and personal observation). Possibly further components analogous to vertebrate
tissue factor are released from damaged cells and induce the clotting process. Evidence
for this assumption may be provided by the hypothetical, so far not purified protein
hemokinin, which is released from damaged epidermal cells of Hyalophora cecropia
and leads to formation of haemocyte clumps (Cherbas, 1973). Some researchers
distinguished two general phases of insect haemolymph clotting, cellular aggregation
and plasma gelation (Grégoire, 1974). After centrifugation of haemolymph samples
coagulation was only observed in a small layer right above the sedimented haemocytes.
In addition, clotting ability of the plasma could be restored by supplementation with
haemocytes (Bohn, 1986). In conclusion it is likely that both haemocytes and cell-free
plasma contribute to insect haemolymph clotting.
Haemocytes in the process of coagulation undergo a number of morphological
changes: They increase in size, form vacuoles and cytoplasmatic blebs resembling
apoptotic vesicles, before they finally degranulate and discharge intracellular material.
Substances released from granules precipitate and form a dense meshwork (Bohn 1986).
It is important to note that degranulation does not necessarily imply death of the
involved haemocytes (Grégoire, 1974), although disintegration of cells participating in
clotting frequently occurs (Rowley & Ratcliffe, 1976). Clot morphology and the
contribution of haemocytes in its formation have been studied extensively since long
(Yeager & Knight, 1933). Grégoire proposed three different patterns of haemolymph
clotting depending on the presence of large veil-like structures and “coagulation
islands”, the formation of pseudopodial meshworks or a combination of both (Grégoire,
1951). The possibility that the described cellular changes might simply represent a
preparation artefact or necrotic cell death rather than a functional cellular process can be
rejected, since haemocyte alterations are effectively inhibited by adding EDTA and
other chemical agents to the medium (Bohn, 1986 and personal observations).
Coagulation was investigated most extensively in lepidopterans, in which granular cells
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are the subgroup of haemocytes involved in clotting (Bohn, 1986, Rowley & Ratcliffe,
1976). So-called coagulocytes, cystocytes or thrombocytoids were repeatedly described
as a specialised haemocyte class with extremely large cell size, fragile membranes and
numerous granules (Goffinet & Grégoire, 1975, Ravindranath, 1980). However, since
these cells are not recognisable prior to clotting, it remains to be clarified if they “cause
coagulation or are the result of coagulation”, as noted by Gupta (1969).
The haemolymph coagulogens of the orthopteran insect Locusta migratoria (Brehélin,
1979, Gellissen, 1983, Duvic & Bréhélin, 1998) and the cockroach Leucophaea
maderae (Barwig, 1985) were proposed to be identical with lipophorin. Intriguingly,
locust lipophorin also aggregates spontaneously after wounding (Chino et al., 1987). In
the lepidopteran Manduca sexta hemofibrin, a protein present in the cell-free plasma,
forms a fibrous clot (Geng & Dunn, 1988). Other proteins in M. sexta, namely the serine
protease-like scolexin (Finnerty et al., 1999) and the lectin M13 (Minnick et al., 1986),
are possible activators of the coagulation reaction. Injection of a recombinantly
produced part of the large protein hemocytin from Bombyx mori into larvae led to
haemocyte aggregation (Kotani et al., 1995). A highly identical protein has been
characterised on the nucleic acid level in Manduca sexta (Scholz, 2002). This protein is
stored in the granules of granular cells in M. sexta. D. melanogaster has been the major
model organism during the last decades in regard to immunity and other aspects of
insect biology. However, until now no investigations have been exclusively devoted
neither to clot morphology nor to the molecular identity of the implicated factors in this
species. Recently hemolectin, a Drosophila protein with high similarity to Bombyx mori
hemocytin, has been characterised (Goto et al., 2001) and a role in haemolymph
coagulation on basis of a wound healing defect was proposed (Goto et al., 2003).
A gene for transglutaminase with high sequence similarity to the enzyme in crustaceans
and horseshoe crabs is present in Anopheles gambiae and D. melanogaster and a
function for this enzyme in insect haemolymph clotting is very likely (Korayem et al.,
unpublished data). Transglutaminases thus seem to represent the final cross-linking
enzymes in all coagulation systems of vertebrates and arthropods investigated so far.
Possible reasons for this conserved feature and the otherwise quite variable clotting
factors in arthropods will be discussed in chapter 4.7.
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1.6   Glycoproteins and lectins –
        interactions of haemocytes and pathogens
Many proteins involved in vertebrate immunity including most factors of the clotting
cascade are glycosylated. The glycosylation state regulates assembly of the MHC- and
T-cell complexes (Rudd et al., 2001). Cell-surface glycoproteins like CD43 might also
contribute to the induction of apoptosis after association with lectins, carbohydrate-
binding proteins (Tsuboi & Fukuda, 2001).
In general, gel-forming polymers often consist of glycoprotein monomers (Smith,
2002). Sugar modifications can be linked to a protein core by N- or O-glycosylation.
Mucins, a group of multifunctional strongly O-glycosylated proteins, are mostly known
for their presence in vertebrate mucus lubricant, but they can as well be integral cell
membrane proteins (Hilkens et al., 1992). The mucus-type mucins are released from
intracellular granules, oligomerise via disulfide bridges and form a gel by hydration
(Hilkens et al., 1992). The function of mucins lining the peritrophic membrane of
insects might be analogous to the ones present in vertebrate mucus, namely the
inhibition of pathogen invasion into the midgut (Shen et al., 1999, Wilkins &
Billingsley, 2001).
Cell agglutination is frequently catalysed by calcium-dependent multivalent lectins
connecting cell surface glycoproteins (Sharon & Lis, 1989). In addition, lectins bind to
microbial carbohydrates, thereby mediating host-pathogen interactions, which include
both host invasion mechanisms and pathogen recognition systems (Mandrell et al.,
1994). Lectins in insect haemolymph may thus establish contacts between haemocytes
and pathogens and act as opsonins for phagocytosis (Pendland & Boucias, 1986,
Renwrantz, 1986, Franc & White, 2000). A clustering effect of several glycoproteins on
a small portion of the cell membrane might be important for activation (Vasta et al.,
1996) and promote pathogen uptake. The bound state of insect membrane glycoproteins
or lectins possibly also initiates the release of granular material, which includes large
amounts of mucopolysaccharides (Gupta, 1991). As a result, the degranulated material
might induce the prophenoloxidase cascade (Renwrantz, 1986), since carbohydrates and
bacterial lipopolysaccharides trigger enzyme activation (Ashida & Yamazaki, 1990). On
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the contrary, mucins on the surface of a cockroach parasite interfere with
prophenoloxidase activation in the host by an unknown mechanism (Brennan & Cheng,
1975) and thereby block an effective immune response. Manduca sexta immulectin-1
stimulates prophenoloxidase activation (Yu et al., 1999). A lectin from the cockroach
Periplaneta americana recognising galactose on pathogen surfaces is involved in
encapsulation (Lackie & Vasta, 1988). Insect haemolymph lectins like M13 from
M. sexta (Minnick et al., 1986) as well as galactose-binding lectins from the dipterans
Sarcophaga bullata (Stynen et al., 1985), Calliphora vomitoria (McKenzie & Preston,
1992) and D. melanogaster (Haq et al., 1996) have repeatedly been implied in
hemagglutination of sheep erythrocytes and insect haemolymph coagulation. Galactose
modifications might therefore represent a general functional property of insect
haemolymph clotting proteins. In agreement with this hypothesis galactose
competitively inhibits adhesion of haemocytes to bacteria and especially interferes
strongly with the attachment of granular cells (Dunphy & Chadwick, 1989). In
summary, insect haemolymph lectins are involved in many immune reactions and seem
to be of general importance for the stimulation of haemocyte aggregation.
In the present study I used lectins to visualise clot structures in D. melanogaster. In
particular an N-acetyl-galactosamine-specific lectin from the snail Helix pomatia and a
galactose-binding lectin from the peanut Arachis hypogaea (“peanut agglutinin”)
proved to be helpful tools. The snail lectin is a marker of vertebrate T-lymphocytes
(Schadlich et al., 1984). In a Drosophila haemocyte cell line, H. pomatia lectin
recognises hemomucin, a Drosophila haemocyte membrane glycoprotein (Theopold et
al., 1996), which is additionally localised in microparticles released from haemocytes
(Theopold & Schmidt, 1997). A. hypogaea lectin labels the Drosophila protein I71-7
(gp150), which is part of the Drosophila haemolymph coagulum (Korayem et al.,
unpublished data). The I71-7 gene is situated within a locus coding for various small
salivary gland proteins of unknown function (Wright et al., 1996). In M. sexta peanut
agglutinin labels the granules of granular cells, bacterial infections in addition lead to a
significant labelling of spherule cells (Beetz, 2002).
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1.7   Hemomucin, a glycoprotein with possible clot functions
The Drosophila haemocyte surface glycoprotein hemomucin (CG 3373) consists of a
mucin-like segment and a domain with sequence similarity to plant strictosidine
synthases, enzymes that catalyse a step in indole alkaloid biosynthesis (Theopold et al.,
1996). Its mucin domain contains numerous potential O-glycosylation sites.
Interestingly a strictosidine synthase-like domain is also present in several other animal
genes, including two genes each in Caenorhabditis elegans and in D. melanogaster
(CG 3373 and CG 11833) and one each in Mus musculus and Homo sapiens (Fabbri et
al., 2000). These genes share the strictosidine synthase-like domain, but many of them
lack the mucin-domain and hence cannot be considered as orthologues of hemomucin.
Hence the term “strictosidine synthase-like” or “SSL” proteins will be used throughout
the present study. There is very little information available about possible non immune-
related functions of the mouse (Albrektsen et al., 2001) and the human member (Morita
et al., 2000) of this protein family. It is appealing that the human protein is strongly
expressed in hematopoietic tissues (Ulrich Theopold, unpublished data). Another
interesting aspect is that both Drosophila hemomucin and the mouse protein are present
in the central nervous system (Ulrich Theopold, unpublished data), which might
implicate additional functions of these proteins.
In Drosophila larvae, hemomucin is found in salivary glands, imaginal discs, fat body,
gut and ovaries (Theopold et al., 2001). In adult flies hemomucin is located in
haemocytes, ovaries and in the peritrophic matrix (Theopold et al., 1996). From the
adult ovaries hemomucin is also deposited on the surface of eggs. Using H. pomatia
lectin to label hemomucin the protein was detected in granules of SL2 cells and
particles released by the cells. Similarly, incubation with the lectin led to labelling of
microparticle-like structures shed from Galleria haemocytes (Theopold & Schmidt,
1997), which may indicate the presence of a similar glycoprotein in this species that is
released from haemocytes upon activation. Drosophila hemomucin also forms
complexes with lipophorin from both G. mellonella and D. melanogaster (Theopold &
Schmidt, 1997). From the data collected so far, hemomucin is likely to be a protein
involved in clotting.
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1.8   Phospholipids and eicosanoids –
        a link between apoptosis, clotting and immunity ?
In all eukaryotic cells, the lipid composition of the inner and outer cell membrane layer
differs significantly, negatively charged phospholipids being confined to the inner
leaflet. Three different energy-dependent pumps - translocases, floppases and
scramblases – actively transport lipids to the opposite side of the bilayer to maintain the
described lipid asymmetry (Bevers et al., 1999). Cell surface blebbing and the exposure
of anionic phospholipids on the outer leaflet are features observed during early
apoptotic, but not in necrotic processes (Bevers et al., 1999) and are evolutionarily
conserved (van den Eijinde et al., 1998). The presence of normally intracellular
components on vertebrate blood cell surfaces was suggested to act as an intrinsic
“danger signal” to initiate an immune response that is pathogen-independent
(Matzinger, 1998, Gallucci & Matzinger, 2001).
Loss of lipid asymmetry is also a significant characteristic of activated platelets (Zwaal
et al., 1998) and regulates vertebrate clotting (Lentz, 2003). Increased levels of
phospholipids, especially on platelet membranes, stimulate coagulation by reducing the
Km of clotting factors (Davie et al., 1991). Nevertheless, the well-established dogma
that platelet surfaces are essentially required as crystallisation points for the reaction
does no longer hold true, since membranes can be substituted by soluble phospholipids
(Majumder et al., 2002). Conversely, anti-phospholipid autoantibodies in the blood of
patients with systemic lupus erythematosus (SLE) block the normal regulation and
cause coagulation defects (Casciola-Rosen et al., 1996). Suramin, an inhibitor of
aminophospholipid translocase reduces activation of several human clotting factors
(Horne et al., 1992).
Furthermore platelets form membraneous protrusions and release microparticles during
clotting. Microparticles are small vesicles containing large amounts of anionic
phospholipids and show both pro- and anticoagulant activity (Barry & FitzGerald,
1999). This regulative function of microparticles was suggested to be carried out mainly
by supplying a phospholipid-rich surface as an assembly matrix for clotting factors,
especially for the prothrombinase complex (Jy et al., 1995). Neutrophils are aggregated
with each other in reaction to microparticle exposure (Jy et al., 1995). This
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agglutination is achieved by the release of granular material from the neutrophils that
forms fibrous networks, so-called NETs (neutrophil extracellular traps) binding to
bacteria and killing them (Brinkmann et al., 2004). One bioactive compound in
vertebrate microparticles is arachidonic acid, an eicosanoid precursor that is hydrolysed
from membrane phospholipids by phospholipase A2. It mediates inflammatory reactions
of leukocytes (Forlow et al., 2000) and interactions with further platelets and
endothelial cells (Barry et al., 1997). For example platelet-activating factor (PAF) is
derived from phospholipids by phospholipase activity within minutes. The
phospholipid-binding annexin V is a vertebrate anticoagulant by clustering on platelet
surfaces (Andree et al., 1992). Moreover, annexin V also inhibits phospholipase A2
activity, thus interfering with eicosanoid biosynthesis (Russo-Marie, 1999).
Intriguingly even in invertebrates, the horseshoe crab clotting factor C is not
dependent on the presence of microbes, but can alternatively be achieved by anionic
phospholipids (Nakamura et al., 1988).
Coagulating insect haemocytes form surface blebs and shed vesicles similar to
vertebrate microparticles (Grégoire, 1951). Annexin V labels phospholipids on these
microparticles in haemocyte lines (Theopold & Schmidt, 1997). It can therefore be
assumed that there is a connection between apoptotic processes and haemolymph
clotting in insects as well. Suramin, the mentioned inhibitor of vertebrate
aminophospholipid translocase, effectively blocks coagulation in different insect groups
(Grégoire, 1953), suggesting the requirement of negatively charged phospholipids for
clotting. Besides the well-known pathogen-dependent prophenoloxidase activation
cascade, enzyme stimulation was proposed to be alternatively elicited by phospholipids
(Sugumaran & Nellaiappan, 1991, Sugumaran & Kanost, 1993). Prophenoloxidase
activation by denatured lipophorin (Ashida et al., 1983, Leonard et al., 1985) or
denaturing agents like SDS (Decker et al., 2001) could be explained along similar lines,
since the bulk of insect lipophorins consists of about 40 to 50 % lipids (Blacklock &
Ryan, 1994), which are exposed during denaturation. Conversely, native lipophorin may
bind and block phospholipids or remove them from the haemolymph. While lipophorin-
depleted haemolymph elevates haemolymph phenoloxidase activity by about 25 %,
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native lipophorin inhibits stimulation of the enzyme (Duvic & Bréhélin, 1998).
Haemocytes from parasitised immune-compromised Pieris rapae caterpillars do not
render their membrane lipid distribution (Asgari et al., 1997), a finding that strengthens
the possible significance of phospholipid exposure as a recognition signal in insect
immunity.
Even in insects the eicosanoid precursor arachidonic acid is hydrolysed from
phospholipids by phospholipase A2 (Howard & Stanley, 1999). Eicosanoids stimulate
insect phagocytosis and activate the prophenoloxidase system (Mandato et al., 1997).
Furthermore they mediate microaggregation reactions in response to LPS (Bedick et al.,
2000), nodulation around injected bacteria (Miller et al., 1994) and fungi (Lord et al.,
2002). Conversely, nodulation is inhibited by the bacterium Xenorhabdus nematophilus
that blocks eicosanoid biosynthesis (Park et al., 2003). The prevention of eicosanoid
production similarly reduces the encapsulation frequency of parasitoid eggs in
Drosophila (Carton et al., 2002). Intriguingly, a regulatory role for eicosanoids in the
Imd pathway leading to antimicrobial peptide production (see chapter 1.4.5) was
reported recently as well (Yajima et al., 2003). Drosophila annexin IX might have
immune-modulating functions similar to vertebrate annexin V by interfering with
eicosanoid synthesis. It is tempting to speculate that annexin IX and lipophorin may act
as anticoagulants in insect haemolymph. Apoptotic features of coagulating cells
possibly also stimulate phagocytosis of haemocytes from the clot by the Drosophila
scavenger receptor encoded by the gene croquemort (Franc et al., 1996, 1999). Since
most antimicrobial peptides act on negatively charged membranes (Boman, 1995), one
might further speculate on an additional role for some peptides in the clearance of
apoptotic cells. It remains to be clarified, if insect haemolymph clotting is triggered,
accompanied or followed by apoptotic events.
In summary, phospholipids on haemocytes and their eicosanoid derivates likely provide
a link to different aspects of insect immunity. This regulation appears quite similar to
the situation in vertebrates and might represent an evolutionary conserved feature.
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1.9   Aim of the projects
As mentioned, only very little information on Drosophila coagulation was available at
the beginning of the present research program. The aim of my work was to fill this gap
and identify and characterise putative insect clotting factors using different approaches.
Since no other candidate clotting proteins of D. melanogaster were described at the
time, I initially chose to study hemomucin, a glycoprotein that was known to be present
in the clot and in insect microparticles. A methodical advantage with hemomucin was
the possibility to use an already existing specific antiserum and Helix pomatia lectin for
labelling and visualisation of the protein. A knock-down of hemomucin by RNA
interference should assist in clarifying the function of the protein in immunity and
development. A mouse protein with high sequence similarity to hemomucin (mSSL)
should be analysed by production of a specific antiserum. It was intended to use this
antiserum to clarify a possible role for the mSSL protein in mouse immune tissues,
which was suggested by data from the human SSL homologue.
While it became increasingly clear that probably many more factors are involved in
insect haemolymph clotting, it remained technically complicated to separate a coagulum
from haemocytes and cellular material to characterise its components. Furthermore
cross-linking of the proteins was supposed to hinder molecular identification. Especially
isolation of the Drosophila clot turned out to be difficult for the mentioned reasons.
Hence, I chose two different methods that both were designed to circumvent these
problems. First I produced an antibody against a haemolymph coagulum isolated from
G. mellonella cell-free plasma. For Drosophila I decided to use a direct proteomics
approach in search for new haemostatic proteins. In D. melanogaster some putative
coagulation factors were then further analysed using mutants and RNA interference.
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2    Material and Methods
2.1  Maintenance of Drosophila and Galleria cultures
2.1.1 Rearing conditions
The Drosophila cultures were maintained in a culture room with a temperature of either
18°C or 25°C and a light/dark-cycle of 12 hours each. All crosses for RNA interference
experiments were carried out at 25°C to ensure activity of the yeast UAS-promoter. For
crosses of different Drosophila stocks virgin female flies were isolated from one strain
and crossed with three to five males each from the other fly line. Experiments described
in this study were carried out with late third instar wandering stage larvae that were
picked from the walls of the culture vials with a brush. In some mutant stocks such as
domino with increased lethality during late larval stages (Braun et al., 1998) the
retrieved numbers of larvae were not sufficient, so that big feeding stage larvae were
chosen from rinsed food in addition. In these instances the larvae used for control
samples also included feeding stage larvae.
Galleria larvae were kept in hard plastic boxes and reared under the same temperature
conditions as described above for Drosophila. Last larval instar wandering larvae were
used in the experiments described in the present study. These were easily recognisable
by the emptied hindgut visible through the integument. The larval development of
Galleria initially takes a long time, but during the last larval instar the larvae grow
rapidly. The cultures were reduced to some individuals only at this stage.
2.1.2   Drosophila food medium
For the preparation of Drosophila food 2,2 l of water were brought to the boil. Then the
following constituents were added under vigorous mixing:
  3 tablespoons dry yeast
    100     ml syrup
80 g mashed potato powder
20 g agar
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The blend was boiled up again for 15 min and then cooled down to 60-70°C under
vigorous mixing to avoid clump formation. Afterwards 17 ml of 10 % nipagin (Sigma;
4-hydroxy-benzoate-methylester) dissolved in 95 % ethanol and 2,5 ml ascorbic acid
were added. To avoid layering of the food, the mix was further cooled down under
stirring to about 50°C (just above the agar solidification temperature) before portioning
it into culture vials and flasks.
2.1.3 Galleria food medium
The following ingredients were mixed together:
100      g baby cereals
200      g  wheat germs
    1,5   g  dry yeast
    0,15 g nipagin (4-hydroxy-benzoate-methylester, SIGMA)
    2         multi-vitamin capsules (TwinLab, “Daily One”)
After reaching a homogenous blend, the remaining components were added slowly
under vigorous stirring to avoid clumping of the food. The medium could be stored for
several weeks at 4°C prior to use. New food was added to the top of the Galleria
cultures in sufficient amounts.
2.2  Drosophila embryo fixation for in situ hybridisation
Freshly laid Drosophila embryos were collected from apple juice plates, dechorionated
in 50 % chlorine solution for 2-3 min and washed several times with water. The
embryos were transferred into an Eppendorf microtube and rinsed with a washing
solution containing 0,04 % Triton X-100 and 0,7 % NaCl. Fixation was carried out in a
ribofix-heptane mixture with the following ingredients and vortexed for 25 min:
1, 4   ml   16 % formaldehyde (electron microscopy grade, Polysciences)
0, 25 ml   10 x PBS
0, 25 ml   0,5 M EGTA, pH 8,0
 0, 6   ml   H2O dd
2, 5   ml   heptane
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The solution was replaced with 0,5 ml heptane and 0,5 ml methanol and shaked
vigorously for 1 min to devitellinise the embryos. After rinsing twice each with
methanol and 99 % ethanol to remove the heptane, the embryos were stored in 99 %
ethanol at -20°C until use.
2.3   DNA microinjection of Drosophila embryos
The vector containing the P-element excision sites and the hemomucin construct for in
vivo production of dsRNA should be injected into Drosophila embryos to generate a
transgenic fly stock. The transposase gene for the P-element transition was added to the
solution on a helper plasmid (“D 2-3”; kindly provided by Ylva Engström) and brought
into an “M cytotype” fly stock (w1118) lacking the transposase gene and natural
P-elements. Furthermore this helper plasmid construct was “wings-clipped”, in which
the IR-sites flanking the transposase gene were deleted. This ensured that the
transposase would not become incorporated into the genome, and the enzyme would be
exclusively active during the next germ cell development only. (Expression of the
transposase in subsequent fly generations would have led to an unstable insertion.)
Integration of the construct in the germ cells was possible, since the DNA was
introduced at an early stage of embryogenesis, when no pole cells (germ cells) had
formed yet in the syncytium lining the outer layer of the embryos. The presence of pole
cells could easily be recognised under the microscope. Thus the construct could be
stably integrated into the germ-line and transmitted to the next generation. Successful
transformation of the plasmid into the genome was indicated by red-eyed flies in the
G1-generation, since the integration plasmid included a copy of the white gene, for
which the acceptor flies had a mutation. Transformed flies were then isolated and back-
crossed with the parental stock for generation of strains with independent insertion sites.
The following protocol for preparation of the embryos was adapted from Roberts
(1998), the microinjection method was originally described by Rubin & Spradling
(1982). Flies were allowed to deposit eggs for 1 h on apple juice agar plates with excess
amounts of yeast to stimulate egg-laying activity. The early stage embryos were
collected, dechorionated in 50 % chlorine solution for 2 to 3 min, washed several times
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with water, followed by a brief rinse in PBS containing a weak detergent to remove
embryos sticking to the walls of the collection sieve. The dechorionated embryos were
mounted on a square of dark-coloured apple juice agar (including charcoal for better
contrast of the white embryos) under the microscope with a fine needle. Later injection
of the embryos at the pole cell-forming posterior end was facilitated by orienting them
in this working step. The eggs were first adjusted with the anterior end (recognisable by
the micropyle) to one side of the agar square and then transferred to a cover slip with a
glue-covered sticky surface. The glue had been prepared from rubber tape dissolved in
heptane over night and was applied to the cover slips some minutes before use to allow
the heptane to evaporate. After 10 min of drying (time varied according to the
temperature and humidity of the environment), the embryos were covered with oil
(Voltalef grade “H10S”; elf atochem, France), which limited the loss of body fluid from
the embryos into the medium in reaction to insertion of the microcapillary. These fine
needles were produced with a needle pulling machine (Narishige, Japan) and filled with
DNA solution (1 mg/ml in PBS) using a drawn-out glass pipette. The cover slip with the
mounted embryos was adjusted close to the capillary under the injection microscope
(Wilovert, Mikron AB) and manually moved into the needle. A defined DNA volume
was injected from the capillary connected to a gas tube by shortly pressing a foot pedal.
Embryos with already formed pole cells were killed by moving the needle right through
them. Finally the cover slip with the injected embryos was placed into a humid
chamber. The H10S-oil was replaced by “H3S” oil (elf atochem, France) with lower
density to allow for sufficient air supply of the developing embryos. Emerging larvae,
which had survived the injection procedure, were collected during the following days
and transferred into food vials for further development.
2.4   Crossings for hemolectin RNA interference experiments
The UAS-hml (hemolectin) construct integrated into the genome of a wildtype fly codes
for the expression of a single-stranded RNA that forms intramolecular base pairs and
thereby is rendered into a double-stranded structure. The transformed flies were kindly
provided by Dr. Akira Goto (Strasbourg, France).
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To activate the yeast promoter UAS, the parental stock had to be crossed with a
Drosophila Gal4-line. The Gal4-protein can be expressed at a certain developmental
stage or in a single tissue by restricting its transcription with a heat-shock or tissue-
specific promoter. In the present study I decided to utilise an Actin5C-Gal4 line to
ensure high levels of ubiquitous Gal4 expression. In addition a haemocyte-specific hml-
Gal4 line was used for other crosses (data not shown).
To guarantee induction of the temperature-sensitive UAS-promoter, the flies and their
offspring were kept at 25°C.
2.5   Maintenance of mbn-2 cell cultures
The Drosophila cell line malignant blood neoplasm-2 (mbn-2) was established from
hematopoietic organs of a haemocyte tumour mutant with the same name (Gateff et al.,
1980). I used cells from this line in the in vitro experiments, since they show a
haemocyte-like appearance and cell physiology. The culture bottles were maintained
with 5 or 15 ml volume of medium. The Drosophila Schneider culture medium (GIBCO
and PAN Biotech GmbH) was supplemented with 10 % fetal calf serum (FCS;
Invitrogen) and 2 mM L-glutamate (GIBCO) before use.
2.6   Collection of haemolymph and haemocyte samples
Haemolymph from G. mellonella was collected by cutting a pro-leg with a pair of fine
scissors, while Drosophila haemolymph was obtained by opening the larvae with a pair
of forceps without disrupting the fat body or other inner organs. Under average
conditions one drop of Galleria haemolymph or haemolymph from two Drosophila
larvae per well were used. The amount of buffer added to Drosophila samples was
minimised to about 5 ml to allow for maximal clot formation. The physiological buffers
employed for haemocyte preparations on object slides were “insect Ringer” for
G. mellonella (Theopold & Schmidt, 1997) and Drosophila Ringer (Goldstein &
Fyrberg, 1994). The haemocytes were allowed to settle down and attach to the slide
during a 10 min incubation time in a humid chamber before application of a cover slip.
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Fixatives were not used, since clot structures were destroyed in the course of several
tested fixation methods. Haemocyte preparations were alternatively labelled with lectins
from A. hypogaea and H. pomatia (20 µg/ml; Sigma) during an incubation period of
15 min to 1 h at room temperature. The specimens were then carefully rinsed with PBS,
mounted with a cover slip and analysed under a fluorescence microscope (Axioskop,
Zeiss).
Haemolymph samples for gel electrophoresis (see chapter 2.13) were either bled
directly into a microcentrifuge tube filled with Drosophila Ringer or collected on a
concaveous depression object slide and transferred into a tube later. If coagulation
should be inhibited, the buffers lacked CaCl2 and instead contained 20 mM EDTA. To
acquire a plasma sample (cell-free haemolymph) the haemocytes were centrifuged down
at 200 g for 15 min. Preparation of the clot samples for the pull-out assay will be
described in chapter 2.12.
2.7   Flow cytometry - Fluorescence-activated cell sorter (FACS)
Hemomucin expression on haemocyte-like mbn-2 cells was studied before and after
addition of the calcium ionophore A23187. For each sample 5 ml of mbn-2 cells were
incubated for 2 h with 2,5 mM, 5 mM, 10 mM and 20 mM calcium ionophore (A23187,
Sigma; dissolved in DMSO) or 20 mM DMSO respectively in Ringer solution. An
additional control sample did not include any chemical. Following incubation the cells
were killed by addition of 0,05 % natrium azide to the medium to stop all cellular
reactions and 0,5 ml were transferred to FACS tubes. Helix pomatia lectin (HPL, FITC-
labelled; Sigma) was added in a final concentration of 20 mg/ml and the tubes incubated
in the dark on ice for 10 min. The fluorescence signal for FITC-HPL was analysed in a
FACScan flow cytometer (Becton Dickinson) and data collected with the CellQuest
software. One sample was treated with propidium iodide (PI) (according to the
manufacturers advice, Sigma) in addition to FITC-HPL in order to recognise the
position of apoptotic cells and cell debris in the FACS output. These cells were
excluded from the analysis. All remaining cells were considered as viable and their
fluorescence levels were investigated at 495 nm.
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2.8   In situ hybridisation of Drosophila embryos
The hemomucin DNA (provided by Dr. Ulrich Theopold) was available integrated in
the pBluescript SK- vector (cloned into the Eco RI restriction site of the multi cloning
site). To avoid cross-reaction of the RNA probe with other mucin RNAs in the embryo,
the gene sequence exclusively contained the strictosidine synthase domain of
hemomucin (internal laboratory plasmid name “Hmu 7”). In a restriction test with
Bam HI and Hind III (method after Sambrook et al., 1989) it was confirmed that the
hemomucin DNA was still present in the vector and no other DNA contamination was
recognisable (gel not shown). To produce larger amounts of DNA, competent E. coli
cells (strain JM 109) were transformed with the plasmid and the plasmid recovered from
the cells according to a standard protocol ( Sambrook et al., 1989). The templates for
the production of a sense and antisense RNA probe were created by linearisation of the
plasmid with two different restriction enzymes Bam HI and Hind III (Sambrook et al.,
1989). The linearised DNA was cleaned in a phenol/chloroform extraction (after
Sambrook et al., 1989) and subsequently used for an in vitro transcription including
digoxigenin- modified UTP nucleotides to label the RNA probes for later detection.
Transcription with the T7 RNA polymerase led to production of the sense probe
(control for in situ hybridisation), while the T3 RNA polymerase gave rise to the
antisense RNA probe (see Figure 4).
        Figure 4: Schematic presentation of the
                         plasmid used for production of the
                         sense and antisense RNA probe
                         of hemomucin
T7 T3
HindIII BamHI
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Protocols for in vitro transcription, dig UTP labelling and in situ hybridisation were
adapted from Tautz & Pfeifle (1989). For the in vitro transcription the following mix
was incubated at 37°C for 2h:
1 ml 10 x transcription buffer (see below)
1 ml 10 x dig U NTP mix (see below)
1 ml 50 mM DTT (Pierce)
1 ml RNase inhibitor (stock 50 units/ml; Ambion)
2 ml linearised DNA (approximately 1 mg)
1 ml T7 or T3 RNA polymerase (Gibco)
3 ml H2O dd
After incubation 16 ml H2O dd were added and 1 ml of the mixture saved to check the
RNA product on a 1,2 % agarose gel together with a standard (gel not shown). Addition
of 25 ml 2 x carbonate buffer (120 mM Na2CO3, 80 mM NaHCO3; pH 10,2) and
subsequent incubation at 65°C for 12 min ensured partial fragmentation of the RNA, so
that it could penetrate the Drosophila embryos. To avoid complete degradation, the
reaction was stopped by a pH change caused by addition of 0,2 M Na CH3COOH
(adjusted to pH 6,0 with acetic acid). Further addition of 10 ml 4 M LiCl, 5 ml
phenol/chloroform-extracted tRNA (20 mg/ml) and 300 ml 99 % ethanol and freezing at
-20°C for 15 min caused RNA precipitation. The RNA was then pelleted by sharp
centrifugation in the cold, washed with 70 % ethanol, dried and dissolved in 150 ml of
hybridisation solution (HS; composition see below). For hybridisation 20 ml of settled
fixed embryos were washed five times for 5 min each in 0,1 % PBST (PBS with 0,1 %
Tween 20) and afterwards once for 5 min in a 1:1 PBST/HS mixture. Afterwards the
eggs were briefly washed three times with HS and pre-hybridised in HS at 55°C for 1 h.
Incubation with 0,2 ml of the probe (two parallel samples for sense and antisense probe)
in 50 ml HS was carried out over night at 55°C. The following day the embryos were
rinsed four times 20 min each at 55°C in HS prior to detection with a preabsorbed
alkaline phosphatase (ALP) labelled anti-dig antibody diluted 1:2000 in 0,5 ml PBST
under shaking for 1 h. The eggs were washed four times with PBST for 15 min each and
then three times in freshly prepared ALP buffer (see below) for 5 min each. The
localisation of the anti-dig antibody was visualised by developing the samples in the
dark with 0,5 ml ALP buffer including 1,75 ml X-phosphate and 2,25 ml NBT. The
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embryos were checked under a dissecting microscope and after about 10 min the
reaction was stopped by washing several times with PBST. Finally the embryos were
embedded on object slides for long-time storage at 4°C.
10 x transcription buffer:
0,4   M 1 M Tris pH 7,5
0,06 M 1 M MgCl2
0,1   M 1 M NaCl
0,02 M 1 M spermidine-HCl
10 x dig U NTP mix:
10  mM ATP
10  mM GTP
10  mM  CTP
  6  mM  UTP
  4  mM  Dig-labelled UTP (all Böhringer Mannheim)
hybridisation solution (HS):
50 %        formamide
  5 x          SSC
       100 mg/ml   heparin
  0, 1 % Tween-20
       100 mg/ml sonicated boiled salmon sperm DNA
ALP buffer (for alkaline phosphatase reaction):
       100 mM   NaCl
50 mM   MgCl2
       100 mM   Tris-HCl, pH 9,5
  0,1 %   Tween-20
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2.9   In vitro transcription of hemomucin RNA for RNAi
The “Hmu 7” vector was used for RNA interference experiments. Since it did not
contain the mucin domain of hemomucin, unspecific interference with other mucin-like
sequences in the cells was avoided. The intron-exon boundaries of hemomucin were
determined with help of the Berkeley Drosophila Genome Project (BDGP) web page
(http://www.fruitfly.org). The DNA template of about 660 bp for the in vitro
transcription was chosen from a region at the start of the fourth exon. It was amplified
from the plasmid in a “nested PCR” consisting of two successive reactions (kit from
Roche, Applied Biosystems) with different primers (Interactiva) to ensure a specific
DNA product (Figure 5). The primers for the second PCR reaction included the
sequence of the T7 promoter (GGA CGA ACT GGC TTT CG) utilised in the following
in vitro transcription. In parallel a GFP dsRNA was amplified from another plasmid as a
control. After the PCR reaction the samples were cleaned up using a PCR purification
kit (QIAGEN) and used as DNA templates using the MEGASCRIPT T7 transcription
kit (Ambion). The RNA products were ethanol-precipitated (method after Sambrook et
al., 1989), resuspended in RNA storage buffer (Ambion) and annealed to dsRNA by
incubation at 65°C for 30 min. RNA interference experiments were carried out
according to the protocol by Clemens et al. (2000) with 15 mg dsRNA (coding for
hemomucin or GFP) added to mbn-2 cell cultures in a concentration of 106 cells per ml.
Figure 5: Production of a dsRNA for hemomucin RNA interference in cell culture
hmu
pBluescript
SK-
T7
T7
T7
T7
1. PCR
2. PCR (with T7-primers)
hemomucin sequence
T7
T7
in vitro transcription (resulting
in dsRNA after annealing)
application to
cell culture
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2.10   Synthesis of a DNA coding for a dsRNA hairpin construct
In addition to a cell culture knockdown of hemomucin, a construct for in vivo down-
regulation of the protein in transgenic flies was produced. The most advanced available
synthesis technique at the time was adapted from a study by Kennerdell & Carthew
(2000) summarised in Figure 6. Briefly, the DNA for the hemomucin gene was
multiplied by two parallel PCR reactions using primers with different restriction sites
added to their ends. As a template the “Hmu 7” construct lacking the mucin domain was
used. After cleaving the PCR products with the endonuclease Sfi I “sticky ends” were
created, which were subsequently ligated to each other. The resulting product consisted
of two copies of the gene sequence, but oriented in opposite directions. Endogenous
transcription from this transgene would therefore lead to the formation of an RNA with
two complementary strands hybridising to a double-stranded structure. Importantly, the
restriction enzyme Sfi I has no specificity for the five central base pairs of the
recognition site GGCC NNNNN GGCC. Using two different primers “Sfi Ia” and
“Sfi Ib” (Figure 6, magnifying glass), the RNA transcripts would later on not be
complementary in this small central region and form a “hairpin loop”. The product from
the first ligation and the cloning vector were subsequently restricted with another pair of
enzymes, Eco RI and Xho I, and ligated into the pUAST vector, which had been
linearised with the same restriction enzymes. After multiplication of the plasmid in
transformed bacteria and recovery with help of ”mini prep” plasmid DNA preparations
this construct was ready for microinjection into Drosophila embryos (see chapter 2.3)
for production of transgenic fly lines. To facilitate an easy screening method for
successful integration of the transgene into the genome, the transposable element also
included the white gene (w+) for red eye colour. The red-eyed flies from the G2-
offspring indicated successful integration of the construct into the fly genome. An
ambiguous result after crosses with the transformants led me to send the construct for
sequencing (KISeq unit at Karolinska Institute, Stockholm). Since the insert was not the
expected hemomucin gene, I did not continue to analyse the transgenic flies. In theory,
after mapping the insertion to the chromosome level, it would have been balanced to
maintain the construct. The hemolectin RNAi-stocks used in the present study (kindly
provided by Dr. Akira Goto) were produced by a similar approach (Goto et al., 2003).
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Figure 6: Schematic presentation of DNA synthesis for in vivo dsRNA
                production from a hemomucin transgene
    (method after Kennerdell & Carthew, 2000)
products from two independent
PCR reactions using different
primers
digestion with EcoRI and XhoI;
ligation into pUAST-vector
with UAS-promoter and
w+-marker; injection into w1118
Drosophila embryos
digest with Sfi I
ligation
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The two PCR reactions were carried out in a thermocycler (Robo Cycler Gradient 96,
Stratagene) utilising a kit (GeneAmp XL PCR kit, Applied Biosystems) for the needed
components. All amounts and incubation times for the reaction were adapted from the
supplied booklet; the reaction was extended for 30 cycles. The PCR products were
cleaned up with the QIAquick PCR purification kit (Qiagen) and the samples resolved
in 60 ml each.
The used primers were synthesised by Thermo Hybaid (Interactiva, Germany) and had
the following sequences. (Restriction sites are presented underlined, the central parts of
the variable Sfi I – recognition site with dotted lines.)
PCR 1: “Eco RI–hmu”: 5`–G GAA TTC CGC TCG AAT GTT AGC–3`
             “hmu–Sfi Ia”:  5`–GGC CAT CTT GGC CCT TGG TAG TGG GTT TCG–3`
PCR 2: “Xho I–hmu”:  5`–G CTC GAG CGC TCG AAG AAT GTT AGC–3`
             “hmu–Sfi Ib”:  5`-GGC CTA GAT GGC CCT TGG TAG TGG GTT TCG–3`
A 1 ml aliquot of the purified PCR product was used on a 1 % agarose gel (Sambrook et
al., 1989) in order to confirm a specific PCR reaction. The subsequent restriction of
both PCR products with Sfi I was carried out with the following components:
     10 ml DNA (PCR product)
         7 ml H2O dd
         1 ml Sfi I (Sigma)
         2 ml restriction buffer (supplied with the enzyme)
The incubation time was initially adjusted to 1 h according to standard conditions, but
later on prolonged to 2 h to ensure total restriction. Additionally the amount of enzyme
used in the reaction was increased to 5 ml (and 3 ml H2O dd only) in some repeated
trials. After restriction the samples were cleaned from the small cleaved-off nucleotides
from the ends of the construct using the PCR purification kit (QIAquick, Qiagen).
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After Sfi I restriction the two PCR products were incubated prior to ligation at 45°C for
10 min to melt unspecifically hybridised DNA-fragments. Afterwards the following
components were mixed together:
product from PCR 1:             5 ml
product from PCR 2:             5 ml
10 x ligase buffer:                 2 ml (composition see below)
DNA ligase (Gibco):             1 ml
milliQ-deionised water:         7 ml
10 x ligase buffer:    0, 1    M MgCl2
                                                0, 5    M Tris-HCl (pH 7,5)
                                              10     mM ATP
                                              50     mM DTT (Pierce)
                                              (dissolved in milliQ-deionised water and stored at -80°C)
Initially the reaction was performed at room temperature for 2 h (according to the
standard protocol for ligation of sticky end fragments). Since the ligation seemed to be
quite ineffective under these conditions, it was later on extended to 24 h and even to
36 h at 4°C. The product of the ligation reaction was purified with the QIAquick PCR
purification kit (Qiagen) and stored at -20°C. An aliquot of the sample was removed for
a control 1 % agarose gel.
In the next working step the sample had to be restricted again with 0,5 ml each of the
enzymes Eco RI and Xho I (Gibco) together with the supplied reaction buffers. In
parallel the pUAST-vector used for the subsequent second ligation reaction was cleaved
with the same enzymes to create sticky ends for the insert. After nucleotide purification
the construct should be ligated into the pUAST-vector. The amounts used for this
ligation were calculated roughly from the band intensities of vector and insert on an
agarose gel (not shown), using the insert at approximately five times excess compared
to the vector. The components for the second ligation reaction were therefore:
vector (pUAST):                           2 ml
insert (ligated PCR products):  10 ml
10 x ligase buffer:                          2 ml
DNA ligase:                                   1 ml
milliQ-deionised water:                5 ml
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A control was prepared in a reaction mix with the linearised vector without the insert in
the same total volume as for the other samples (15 ml H2O dd added). Ligation of the
control reaction was not expected, since the Eco RI- and Xho I-restricted ends should
not be able to hybridise to each other. In a subsequent “PCR purification” step the
samples were cleaned from the ligase and salts. Plasmid transformation was performed
according to Sambrook et al. (1989) using 1 ml of each ligation reaction with and
without the insert (control). Since the competent cells (E. coli, strain JM109, Promega)
were ampicillin-sensitive, successful uptake of the plasmid with a resistance gene
marker was indicated by growing colonies on LA bacteria plates (Sambrook et al.,
1989) including 100 mg/ml of the antibiotic. The plasmid was then recovered from the
bacteria (using the QIAprep SPIN miniprep kit, Qiagen), checked together with
linearised plasmid DNA on a 1 % agarose gel after Eco RI / Xho I restriction and was
ready for injection into Drosophila embryos.
2.11   Recombinant expression of the mouse SSL protein in
          E. coli for production of an antiserum
The EST clone “IMAGE:1512404” coding for the mouse SSL protein was ordered
through the NCBI web page (http://www.ncbi.nlm.nih.gov/dbEST). The cells were
cultured and the EST recovered from the vector (using a plasmid MIDI kit, Qiagen). A
PCR reaction was performed (GeneAmp XL PCR kit, Applied Biosystems) under
standard conditions assuggested by the manufacturer using 1 ml plasmid DNA as a
template. The PCR primers included restriction sites for Bam HI and Hind III at their
ends (underlined bases), facilitating cloning of the product into the pQE-32 vector with
the same recognition sequences in its multi-cloning site. Cleaning of the PCR product
was performed with the QIAquick PCR purification kit (Qiagen). An aliquot of 0,5 ml
was applied to a 1 % agarose gel (not shown) together with linearised plasmid DNA to
check for the right size of the oligonucleotide product and to estimate the volumes for
the following ligation reaction.
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Forward primer “M1” (including Bam HI-site): 
      5` – ATT AGG ATC CAG ATG TCC TTT GTG CTG – 3`
Reverse primer “M2” (including Hind III-site): 
      5` – TTA TAA GCT TTC ATT CTC TTA ATA CAG – 3`
After restriction of both PCR product and vector DNA with the enzymes Bam HI and
Hind III, another purification step was performed. Then the ligation was carried out at
4°C for 24 h using 10 ml of the insert and 2,5 ml of the vector in a total volume of 20 ml
(for all other components see protocol for hemomucin hairpin DNA construct in the last
chapter). A control ligation using restricted vector only was also performed. The
ligation products were cleaned from ligase and small nucleotide contaminants and
transformed into competent E. coli JM 109 cells (Promega) on LA-plates containing
100 mg/ml ampicillin (Sambrook et al., 1989). Plasmid DNA was isolated from growing
clones (QIAprep SPIN miniprep kit, Qiagen) and 5 ml DNA each as well as a sample of
the restricted pQE-32 vector were applied to a 1 % agarose gel (Sambrook et al., 1989).
Transcription of the protein from the plasmid in the successfully transformed bacteria
was stimulated in mid-log phase cultures by induction of the lac-promoter of the
pQE-32 vector with 1 mM isopropylthio-b-D-galactoside (IPTG) for 1 and 2h at 37°C.
Both E. coli clones including and missing the insert (judging from the agarose gel after
transformation) were treated this way. Protein samples were taken from the cultures at
both time points, separated on a 15 % SDS polyacrylamide gel and blotted to a
nitrocellulose membrane for 1 h at 200 mA constant voltage (see chapter 2.13). The
membrane was subsequently incubated with an antibody against a recombinantly
produced part of hemomucin (see chapter 2.13, table 1; kindly provided by Dr. Ulrich
Theopold) in a concentration of 1:5000 in TBST.
Since the used pQE-32 vector included a His-tag epitope, the induced protein with a
molecular weight of about 20 kDa from the cells could be purified on a Ni-NTA column
(Qiagen). The described working protocol was adapted from the Qiagen handbook “The
QIAexpressionist” (chapter 19). Cells were harvested from 1 ml bacterial culture by
centrifugation at 15 000 g for 1 min and lysed by vortexing the resuspended pellet in
200 ml lysis buffer (100 mM NaH2PO4, 10 mM Tris-HCl, 8 M urea, pH 8,0 with
NaOH). Afterwards the cell debris was removed in a 10 min centrifugation step at
15 000 g.
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The supernatant containing the His-tagged recombinant protein was mixed with 50 ml of
a 50 % Ni-NTA resin (Qiagen) and incubated on a shaker for 30 min at room
temperature. The resin with bound proteins was pelleted for 30 sec at 15 000 g and
washed twice with 250 ml of a lysis buffer adjusted to pH 6,3 with HCl. Finally eluates
were collected from three subsequent incubation steps with 25 ml of this buffer adjusted
to pH 4,5. Aliquots of the samples were tested on a 15 % SDS polyacrylamide gel (not
shown). Since the protein recovery from the column was limited, harsher elution
conditions were tried using 10 M urea. The collected protein amount was still too small,
thus it was finally decided to incubate the Ni-NTA beads in sample loading buffer at
90°C for 2 min. The sample was separated on a 15 % SDS gel (see chapter 2.13), which
was destained using solutions lacking acetic acid, which would have interfered with
following working steps. An estimated protein amount of 1280 mg was derived from 1
litre of bacterial culture, which was sufficient for antibody production in two rabbits
(500 mg for each animal had been suggested by AgriSera AB). The 20 kDa protein band
was cut from the gel and sent for antibody production in rabbits (AgriSera AB, Vännäs,
Sweden). The collected antiserum received from the company was tested for reactivity
and specificity on Western blots with different amounts of the recombinant protein from
E. coli cells and with the endogenous mouse protein in different tissues including bone
marrow and platelets. A pre-immune serum from the same rabbits was tested
additionally in all cases to exclude positive signals due to endogenous rabbit antibodies
already present in the serum prior to immunisation (not shown). All mouse tissues were
applied to the gel in samples with a volume of 20 ml in a 1:10 dilution except bone
marrow and platelets samples, which were tested undiluted. The mouse tissues were
prepared under the guidance of Matthias W. Hornef (Microbiology and Tumor Biology
Center, Karolinska Institute, Stockholm, Sweden). It was tried to improve the affinity of
the antiserum for the 20 kDa protein by elution of the immobilised antibodies from the
nitrocellulose membrane using a protocol by Smith & Fisher (1984).
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2.12   Clot isolation with paramagnetic beads in the pull-out assay
A general problem connected to the isolation of a haemolymph clot is the fact that
haemocytes become integrated in the coagulum during the clotting process. Therefore
normal “pull-down” centrifugation methods fail to separate the cells from the protein
fibres. I used paramagnetic beads (tosylactivated Dynabeads M-280, Dynal
Oslo/Norway) to be able to isolate the detergent-resistant clot from the lysed
haemocytes (Figure 7). The beads became passively integrated into the coagulum
during the ongoing reaction. Two kinds of possible unspecific binding reactions to the
beads, physical and chemical, were reported by the manufacturer. Physical binding
occurs in the time range of minutes, but can be reversed through treatment with weak
detergents, as used in the present study. Chemical interactions with the tosyl-activated
groups take place rather in the time scale of several hours and are thus unlikely for the
protocol described here. However, to minimise the risk for unspecifically bound
proteins, the activated groups were blocked with 0,2 M Tris (pH 8,5) as suggested by
the manufacturer. In some cases the beads were coated with PNA over night to enhance
binding of clotting factors (Figure 24). The same proteins, however, were retrieved
using untreated beads.
Figure 7: Principle of the pull-out assay
                 Paramagnetic beads become passively incorporated into the haemolymph
clot (left). They can be separated from the cells together with the detergent-
resistant clot after lysis of the haemocytes (right). Green symbols:
                  haemocytes and cell fragments; red circles: beads; black lines: clot fibres.
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50 ml of Drosophila Ringer including PTU and 50 ml of washed paramagnetic beads in
Drosophila Ringer solution were transferred to a concaveous object slide. Haemolymph
from twenty washed larvae was added by opening them with antimagnetic forceps
submersed in the solution and swirling the sample to maximise contact of the clot with
the beads. Bead aggregation was followed under the dissection microscope during
preparation and photos were taken at several time points with a camera attached to the
microscope. Twenty larvae were used, since the aggregation did not increase visibly in
reaction to further added haemolymph to the sample. In some mutants like domino
homozygous larvae have an increased lethality and are considerably smaller (Braun et
al., 1998). In these cases thirty individuals were used to adjust the haemolymph volume
to a comparable amount.
The beads were transferred together with the buffer into a microcentrifuge tube. The
preparation slide was rinsed with additional 100 m l of Drosophila Ringer to collect
remaining beads, which were added to the sample. The tube was placed into a magnet
holder (Dynal Oslo/Norway) so that the coloured paramagnetic beads were collected at
the tube wall. Subsequently the cleared solution was removed with a pipette, leaving
behind only the beads together with the bound haemolymph clot. Three washing steps
were performed with 100 ml of Drosophila Ringer, three additional rinses with Ringer
including 0,5 % IGEPAL CA-630 (Sigma) and protease inhibitor mix (Complete,
Roche) and finally three washing steps with Ringer. The protease inhibitor was added to
avoid a possible destruction of the clot proteins by intracellular proteases released from
the lysed haemocytes. The beads were incubated with the washing solution for 1 min
each, the first detergent washing step was allowed to proceed for 2-3 min. The washed
beads were resuspended in 20 ml 1x sample loading buffer (Laemmli, 1970).
2.13 Polyacrylamide SDS gel electrophoresis and Western blots
For polyacrylamide SDS gel electrophoresis and Western blots a minigel system
(MiniProtean, BioRad) was used. The standard method described by Laemmli (1970)
was followed; all buffers and solutions were prepared according to Sambrook et al.
(1989). All samples were mixed with sample loading buffer to a final 1x buffer
concentration and denatured prior to freezing and prior to gel electrophoresis,
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respectively, by incubation at 80°C for 2 min. The proteins and a standard (Cat. No.
161-0373, BioRad) were separated by electrophoresis in 10 % and 5 % resolving gels.
The electrophoresis was performed at constant voltage of 25 mA for the stacking gel
and 30 mA for the resolving gel. The protein bands were visualised in the gel by either
staining with Coomassie (Coomassie Brilliant Blue G, Sigma) or a silver staining kit
(Amersham Biosciences). Destaining of the gel was carried out as suggested by the
suppliers, but acetic acid was excluded from all buffers, if a protein sample from the gel
should be sent for sequencing.
For labelling with antibodies and lectins, the proteins were blotted to a nitrocellulose
membrane (BioRad) at 200 mA for 2 h. The membrane was blocked in TBST (TBS
including 0,05 % Tween 20) for 1 h and incubated with the lectin or antiserum (see
table 1). Hemomucin was detected by one of two antibodies (kindly provided by
Dr. Ulrich Theopold) or the H. pomatia lectin (HPL; peroxidase conjugated; 1:10 000
v/v; Sigma). Similarly the lectin peanut-agglutinin (PNA; peroxidase-labelled; working
solution 1:1000 v/v; Sigma) was used to visualise clot components on Western blots
applying the same incubation times and washing steps as described before. The blots
were washed four times 15 min each in TBST under vigorous shaking. A secondary
antibody (goat-anti rabbit; alkaline phosphatase (ALP) conjugated; 1:20 000 v/v;
Sigma) was added for 1 h and the membranes were washed again four times, 15 min
each with TBST. Development of the ALP-reaction was carried out with BCIP and
NBT (Sambrook et al., 1989). Membranes labelled with HPL were developed with
1:1000 v/v H2O2 (40%) and 6 mg/10 ml 3'3'-diaminobenzidine tetrachloride (DAB) in
10 mM Tris pH 7,5 was started directly after lectin treatment and four TBST washing
steps (Sambrook et al., 1989).
Table 1: Primary antisera used in the present study
antiserum specificity origin raised against reference
anti-hemomucin polyclonal rabbit protein from Dr. mel. Theopold et al., 1996
anti-hemomucin
recombinant
polyclonal rabbit rec. protein in E. coli
(part of SSL-domain)
Fabbri et al., 2000
anti-hemolectin polyclonal rabbit rec. protein in E. coli Goto et al., 2001
“anti-clot “ polyclonal rabbit Galleria in vitro clot Li et al., 2002
anti-mouse SSL
(anti-mSSL)
polyclonal rabbit rec. protein in E. coli
(from EST-clone)
present work
(chapter 2.11)
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2.14  Mass spectrometry of proteins from the pull-out assay
The most prominent protein bands from a pull-out sample were cut out with sterile
stainless steel blades from a Coomassie-stained gel for mass spectrometry
characterisation, transferred into siliconised tubes (“Maxymum Recovery”, Axygen)
and sliced into small gel bits. The sliced gel pieces were washed in three or more
successive incubation steps by vortexing in 100 ml of 25 mM NH4HCO3 in 50 %
CH3CN until they were completely destained. Next the gel was dehydrated by vortexing
in 100 ml CH3CN for 5 min and then dried in a Speed Vac. The proteins were digested
in 20 ml of 12.5 ng/ml sequencing grade trypsin (Promega V511A) in 50 mM NH4HCO3.
After vortexing the gel pieces in this solution for 10 min, the tubes were covered with
parafilm and incubated at 37°C for 16-20 h (over night). The peptides were solubilised
by vortexing for 1 h in 50 ml of 50 % CH3CN/5 % trifluoroacetic acid. Afterwards the
gel pieces were pelleted and the supernatant transferred to a new siliconised tube. This
extraction step was repeated twice. Finally the combined supernatants were centrifuged
under vacuum until dry (approximately 2 to 4 h). Prior to mass spectrometry analysis
the pellet of recovered peptides was resuspended in 2 to 5 ml of 50 % CH3CN/0.1 %
trifluoroacetic acid, depending on the estimated amount of protein. Mass spectra were
recorded in positive reflection mode by using a mass spectrometer equipped with a
delayed ion extraction technology (MALDI-TOF Voyager-DE STR, Applied
Biosystems). As a matrix a-Cyano-4-hydroxy-cinnamic acid (CHCA) was chosen.
External calibration was performed using the Sequazyme Peptide Mass Standard kit
(Angiotensin I and ACTH, clips 1-17, 18-39, 7-38) and auto digestion peaks of bovine
trypsin were used for internal calibration. The peptide profiles produced by mass
spec t romet ry  were  ana lysed  us ing  the  p rograms  Masco t
(http://www.matrixsciences.com/), ProFound (http://prowl.rockefeller.edu/), MS-Fit
(http://prospector.ucsf.edu/) and PeptIdent (http://www.expasy.org/tools/peptident.html). The
monoisotopic (MH+) peptide masses were compared with the theoretical masses derived
from the NCBI database entries for Drosophila melanogaster. Known masses of trypsin
autodigest products were excluded from the searches. Search parameters included
allowed mass accuracy of 50 ppm, more than four peptide mass hits required for a
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protein match, consideration of maximal one missed enzymatic cleavage, a pI range of
0.0-14.0, and a molecular mass range of 1-3000 kDa. Carbamido-methylation of
cysteine residues was set as a complete modification for the retrieved peptide sequences
and partial oxidisation of methionine was allowed. The protein matches were only
accepted as meaningful, if analysis with two of the mentioned programs independently
led to significant matches for the same protein. In ProFound e-values above 1,645 were
considered significant (synonymous with a significance level of 95 %), while the inbuilt
significance threshold of 95 % in Mascot was adapted. Peptide mass data collection was
kindly performed by Christine Karlsson and Olga Loseva (Department of Molecular
Biology & Functional Genomics, Stockholm University).
2.15 Preparation of total RNA from Drosophila larvae for RT-PCR
I investigated a possible induction of hemolectin in larvae and adults from different time
points after poking with a fine tungsten needle (Fine Science Tools). Larvae were
pricked at the posterior end close to the spiracles, in adults the needle was applied at the
weaker cuticle at the wing attachment sites. Poked larvae and adults were transferred to
a vial with fly food to ensure sufficient food availability and air humidity. In parallel
non-poked larvae and adults were transferred to new tubes and used as control samples
to check for possible developmental effects on the RNA level (1 h and 24 h). The
pricked individuals were collected after 1, 6, 12 and 24 h, washed with water,
transferred into microtubes and stored in liquid nitrogen to immediately stop all
transcriptional activity. Larvae that had died from too harsh pricking were excluded
from the experiment. (All adult flies survived the procedure.) RNA preparation was
performed using a kit (RNeasy, Qiagen) and following the supplied protocol. Five
larvae in 700 ml RLT-buffer were used for each sample and homogenised using
polypropylene pellet pestles (Sigma). The RNA was extracted in the final elution step
with 50 ml RNase-free water per sample and RNA-concentration was measured at 260
nm in a photometer (BioRad). A calculated RNA equivalent of 0,5 mg each was further
tested on a 1,2 % agarose gel including formaldehyde (Sambrook et al., 1989; gel not
shown). The calculated RNA-concentrations proved to fit quite well with the actual
band strengths.
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2.16   Test for wound-induced induction of hemolectin using
          RT-PCR
A possible induction of hemolectin transcription by pricking should be checked using
reverse transcription polymerase chain reaction (RT-PCR). Since the RNA
concentrations for the reactions were adjusted approximately, the RT-PCR may be
characterised as “semi-quantitative”. Two different pairs of forward and reverse
complementary primers were used in two parallel test reactions, one pair was adapted
from a previous study on hemolectin (242 bp fragment complementary to amino acids
6819-7061; Goto et al., 2001), the other pair was chosen from a list of suggested
primers employed for microarrays (http://www.affymetrix.com). Since both primer
pairs proved to lead to a comparable band intensity for hemolectin in test gels (not
shown), only the primers from Goto et al. (2001) were used for the RT-PCR reactions
shown here. Primers for the ribosomal protein RP49 (constitutive expression) were
employed in control samples for each time point (480 bp product; primer sequences
adapted from Goto et al., 2001). The optimal hybridisation temperature for the RP49-
primers was determined as 52°C, while the hemolectin-primers annealed best at 59°C.
In test reactions 21 reaction cycles were found to lead to a weak but visible signal for
hemolectin (not shown), thus ensuring the recognition of an induction elevating the low
constitutive background transcription level. Each RNA-sample was used for two
independent PCR reactions using primers for RP49 or hemolectin. The RT-PCR was
performed in a thermocycler (Robo Cycler Gradient 96, Stratagene). A thermostable
DNA polymerase from Thermus thermophilus with intrinsic reverse transcriptase
activity (Gene Amp EZ rTth RNA PCR Kit; Applied Biosystems) allowed the
performance of both reactions (reverse transcription and DNA amplification) in a single
sample mix. The used RNA amounts, components of the PCR mix and all cycling
conditions were adapted from the manual supplied by the manufacturer.  Briefly, an
initial reverse transcription reaction at 60°C for 30 min was followed by a standard PCR
protocol for 21 cycles with each cycle consisting of a denaturation step at 94°C, a
combined primer annealing and extension step at 52 or 59°C respectively and a final
elongation step at 72°C. The different optimal annealing temperatures for each primer
pair were applied by using the gradient heating block of the thermocycler.
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3     Results
3.1   Studies on localisation and functions of hemomucin
3.1.1 Detection with Helix pomatia lectin and an antiserum
One of the first candidate proteins for a haemolymph clotting factor in Drosophila
melanogaster was hemomucin, since it was known to be localised in haemolymph clots.
Detection of hemomucin can be achieved by labelling with the lectin from Helix
pomatia (HPL) in both the clot preparation and on Western blots. Alternatively a
hemomucin-specific antiserum can be used which recognises antigens of the denatured
protein only (Theopold et al., 1996), while labelling of the native protein is not possible.
The expression of hemomucin in other larval and adult tissues than haemocytes
(Theopold et al., 1996, 2001) suggested a broader biological role for this protein.
Hemomucin is poorly detected with the lectin on membranes with Drosophila
haemocyte samples (Figure 8 and Dr. Ulrich Theopold, personal communication). In
cell samples from mbn-2 cultures the lectin binds hemomucin more efficiently (Figure
13, first lane). The antiserum clearly labels hemomucin in the haemolymph (Figure 8,
arrow) and weakly binds to the protein present in haemocytes (not visible in Figure 8).
Hence the antiserum was utilised on Western blots, while haemocyte monolayer
preparations were labelled with HPL.
Figure 8: Simultaneous double detection
     with an antiserum against
     hemomucin and HPL-reactive
     proteins in a clotted haemolymph
     sample of Drosophila
arrow: specific detection of hemomucin with
            an antiserum directed against the full-
 length protein (see chapter 2.13, table 1;
 secondary antibody labelled with
 alkaline phosphatase); weak hemomucin
 signal in haemocytes not visible here
stars:   several cellular HPL-reactive
            haemocyte proteins
 (HPL labelled with peroxidase)
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3.1.2   In situ hybridisation of Drosophila embryos
Based on expression data from larval (Theopold et al., 2001) and adult stages
(Theopold et al., 1996) of D. melanogaster it was hypothesised that hemomucin might
be involved in hardening processes in general, which might include embryonic
development as well. Furthermore it had not yet been investigated, if hemomucin is also
produced by embryonic hemocytes. Since no data was available at the time on the
presence of hemomucin in Drosophila embryos, its expression was studied by in situ
hybridisation (see chapter 2.8). The probe was synthesised from a part of the
strictosidine synthase-like domain to avoid unspecific cross-reactions with the mucin
domain of other proteins. Hemomucin transcripts were detected in the distal part of all
blastoderm cells after cellularisation in stage 5 embryos (Figure 9). During later time
points of embryonic development, at about stage 14, hemomucin RNA was expressed in
fore- and hindgut, salivary glands and tracheae. Examination of the preparations at
higher magnifications revealed that the probe was located in the epithelia of trachea and
gut and not in their lumen (not shown), speaking against a possible unspecific staining
reaction. The control hemomucin sense RNA probe did not give rise to any signal (not
shown).
In addition to in situ hybridisations with hemomucin probes, labelling was alternatively
performed with an RNA probe against the second strictosidine synthase-like protein in
D. melanogaster, CG 11833 (Figure 10). RNA coding for this protein was present in the
trachea as shown for hemomucin. In addition a paired structure in the pseudo-cephalic
region (ps) and the pharynx (p) were labelled.
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Figure 9: in situ hybridisation of Drosophila embryos with a hemomucin RNA probe
                a:   stage 5:      weak expression in the whole embryo (?)
                b:   stage 5/6:   strong expression in the basal parts of the syncytium
                c-f: stage14:     expression of hemomucin in fore- (fg) and hindgut (hg),
                                           salivary glands (sg) and trachea (t)
 (Figures c/d: lateral view, Figures e/f: dorsal view; in all pictures the anterior
  end is oriented to the left side, the posterior end to the right)
t
fg sg hg t
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Figure 10 a-f: in situ hybridisations with an RNA probe for the second
                        strictosidine synthase-like Drosophila protein (CG 11833)
                        (stage16/17), pharynx (p),”pseudo-cephalic region” (ps), trachea (t)
ps
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3.1.3 Studies on microparticle formation in a haemocyte-like cell line
Since hemomucin is localised on microparticles released from insect haemocytes
(Theopold & Schmidt, 1997), it was hypothesised that it may be shed from the
haemocytes into these particles, leading to a depletion of the protein from the cells. The
calcium ionophore A23187 is used in vertebrate studies to induce platelet microparticle
formation in vitro and stimulates comparable cell changes in Drosophila mbn-2 cell
cultures (not shown). HPL was used as a tool to detect hemomucin in a FACS analysis
of cells from the haemocyte-derived Drosophila cell line mbn-2 (see chapter 2.7), since
antibody labelling was not feasible for the native protein. The working hypothesis was
that the lectin signal intensity of ionophore-treated cells would be lower than the one of
untreated cells. In fact mbn-2 cells showed a weaker HPL-labelling after incubation
with the ionophore A23187. This effect could already be observed after treatment with
comparably low ionophore concentrations of 2,5 mM and was even stronger at higher
concentrations (Figure 11). Since the ionophore had to be diluted in DMSO, a sample
treated with this chemical alone in a high concentration was used as a control, which did
not cause any reduction of HPL-labelling. A differential reaction of the cells to the
ionophore could be observed, the cell population II (Figure 12C; “Pop II”) did not show
any change in HPL-labelling in contrast to cell population I (Figure 12B, “Pop I”).
Figure 11: FACS analysis of hemomucin levels in mbn-2 cells treated with the
                   calcium ionophore A23187, detected with FITC-labelled HPL
 green: untreated cells; red: 20 mM DMSO (control);
                 white: 2,5 mM ionophore A23187; blue: 20 mM ionophore A23187
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Figure 12: Differential reaction of two cell populations to ionophore treatment
                   A: fluorescence signal of the total cell sample; the lectin labelling was
                        different for two cell populations “Pop I” and “Pop II”
                   B: cell population I, C: cell population II
       blue: 20 mM ionophore A23187
                   red: control sample (no ionophore added)
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3.1.4   In vitro transcription and hemomucin RNAi in cell cultures
No Drosophila mutant for hemomucin was available from the common stock centres,
hence I decided to down-regulate the protein by RNA interference (RNAi) in
haemocyte-like cell cultures (see chapter 2.9). Hemomucin dsRNA as well as a control
dsRNA of the GFP gene were applied directly to an mbn-2 cell culture. After three days
of incubation (the usual initiation time for RNAi) the cells were sedimented by
centrifugation and labelling with H. pomatia lectin was performed on a Western blot. A
substantial down-regulation of hemomucin could be observed in the treated cells
(Figure 13). Nevertheless no obvious changes in cell morphology had occurred after
three days and even after fourteen days and repeated dsRNA application. The
membrane of RNAi-treated mbn-2 cells could also still labelled with HPL (not shown).
                     
Figure 13: Decrease of hemomucin in mbn-2 cell cultures after treatment with
                   hemomucin dsRNA and a control GFP dsRNA
                   (10 % SDS-polyacrylamide gel; detection with HPL, labelled with alkaline
        phosphatase; star indicates position of hemomucin)
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3.1.5   Synthesis of a DNA construct for hemomucin RNAi in vivo
Since the RNAi technique worked well for hemomucin in cell culture (Figure 13), I
decided to produce a DNA hairpin construct for endogenous expression of a
hemomucin dsRNA in a transgenic fly stock (see chapter 2.10). All steps of the working
protocol were controlled on agarose gels. Both PCR products were found to consist of a
single oligonucleotide with the expected size of about 650 bp each (Figure 14). The
Sfi I restriction and the subsequent ligation were repeated several times and
modifications to the working protocol were adapted after discussions with colleagues.
However, these experiments led to only few successfully ligated products. The band in
the 1350 bp range was always very weak (Figure 15, lane “Lig”), but reproducibly
disappeared after restricting the product again with Sfi I, indicating successful ligation
(Figure 15, lane “R”), indicating that the construct sequence was right.
        M       PCR 1   PCR 2                                       R            M           Lig
Figure 14: Control for the two PCR              Figure 15: Test gel to check efficacy of
products for in vivo down-regulation             Sfi I-restriction and the first ligation
of hemomucin                                                   
M: molecular weight standard;                          M:   molecular weight standard;
PCR1, 2: two independent PCR reactions         R:    ligation product restricted with Sfi I;
                                                                           Lig: ligation product (light arrowhead)
                                                                                   (lower band: non-ligated DNA)
2027 Bp
1904 Bp
1584 Bp
1375 Bp
  947 Bp
  831 Bp
1904 Bp
1584 Bp
1375 Bp
  947 Bp
  831 Bp
  600 Bp
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Even the final ligation of the insert into the vector was controlled on a gel after Eco RI /
Xho I restriction. Only few bacterial colonies seemed to have integrated an insert. DNA
from these clones was analysed on the gel presented in Figure 16.  The size of the
fragments integrated in the plasmid from preparations 1, 3 and 6 was in the 1500 bp
range expected for the hmu-umh inverted-repeat insert.
      restricted (R) and unrestricted mini plasmid preparations                   pUAST
     1        1R        2        2R       3       3R      4R     5R       6       6R      M      unr.   restr.
Figure 16: Control gel with plasmid DNA preparations after the second ligation
(1-6: different unrestricted plasmid preparations, 1R-6R: samples restricted with Eco RI
and Xho I prior to gel electrophoresis to recognise insert sizes)
Since the cloning was considered successful, the plasmid was amplified and injected
into Drosophila embryos. However, when the insert was sequenced N-terminally at a
later stage (done by the KISeq unit at Karolinska Institute, Stockholm), it turned out that
it was in fact a gene coding for an E. coli transposon. In summary, the attempt to
synthesise a DNA construct for inheritable in vivo RNA interference of hemomucin was
not successful despite numerous attempts.
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3.2   Recombinant expression of the mouse SSL protein in
        E. coli  for production of an antiserum
The genomes of several organisms include one or more copies of genes with similarity
to the strictosidine synthase-like domain of hemomucin and are therefore termed “SSL
proteins” (see chapter 1.7). Interestingly the human SSL protein is strongly expressed in
hematopoietic tissues (Ulrich Theopold, unpublished results). Since the presence of the
mouse member of the SSL-family (mSSL) in immune tissues had not yet been
investigated, I tried to produce an antiserum against a recombinant mouse SSL protein
(see chapter 2.11). A publicly available EST clone for mSSL was obtained and
restriction sites were added to its sequence in a PCR reaction. After ligation into the
pQE32-vector successful integration of the mouse SSL DNA into the plasmid was
tested on an agarose gel (Figure 17).
                      M      pQE32        plasmid preparations after ligation
                              unr. restr.     1      2       3       4        5      6        7
Figure 17: Control of the ligation of the EST-derived sequence for mouse SSL
into the pQE-32 vector after Bam H I / Eco RI restriction
                   (M: marker; unrestricted and restricted plasmid;
                    1-7: different plasmid preparations of bacterial colonies after ligation;
                    black arrowhead indicates the position of the insert)
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Four of the eight tested ligation reactions (1, 2, 4 and 7) had led to integration of the
DNA coding for the mouse protein. Total protein samples from the IPTG-induced
E. coli cells were analysed on a nitrocellulose membrane with the antiserum against a
recombinant part of the Drosophila hemomucin SSL-domain (Figure 18). The major
band recognised by the antiserum was in the 20 kDa range, indicating a good affinity of
the hemomucin antiserum for the recombinant mSSL protein from E. coli.
           1      2      3      4      5      6      7      8      M     9    10    11    12
Figure 18: Expression of recombinant mSSL protein detected with an antiserum
                   against hemomucin (15 % SDS-polyacrylamide gel;
                   1-6: clones without integrated mSSL construct; mSSL-expression after 2 h
                   (7, 9, 10) and 1h (8, 11, 12) IPTG-induction indicated by arrowhead)
It was attempted to purify the recombinant mouse SSL protein over a Ni-NTA column
utilising the His-tag of the pQE-32 vector. It turned out that the eluate of the proteins
bound to the bead matrix included not only mSSL, but numerous additional proteins
(not shown). Elution efficiency of the mSSL protein increased after prolonged
incubation, suggesting a strong binding affinity of the protein to the beads. After testing
harsher elution conditions, finally the beads were cooked to bring all proteins into
solution. A huge amount of mSSL protein gained choosing this approach was isolated
from a 15 % gel and used for antibody production (see chapter 2.11).
The antiserum was initially tested on the recombinant produced mSSL-protein from
E. coli cells to confirm the specificity of the antibody (Figure 19).
100 kDa
  75 kDa
  50 kDa
  37 kDa
  25 kDa
  16 kDa
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                                  1          2          3          4          5          6          7
Figure 19: Incubation of total protein samples from E. coli with the antiserum
                  against recombinant mSSL on a Western Blot (antibody diluted 1:1000;
                  1: E. coli, 2/3: E. coli + 1 mM IPTG, 4: E. coli + mSSL,
      5-7: E. coli + mSSL + 1 mM IPTG, marker not shown;
      black arrowhead: ~ 20 kDa band represents recombinant mSSL protein)
Among proteins from the transformed bacteria the antiserum showed strongest activity
against the 20 kDa band representing mSSL (Figure 19, arrowhead), even though
additional proteins were recognised. Only weak unspecific cross-reactions of the
antiserum with endogenous E. coli proteins were observed (Figure 19, gel lanes 1-3, not
visible in figure). The detection signal of the 20 kDa protein could even be slightly
improved by using a higher dilution of 1:5000 v/v of the antiserum (not shown). The
mSSL protein was already expressed by transformed bacteria prior to induction of the
lac promoter with IPTG (Figure 19, gel lane 4). No signals were visible on a membrane
incubated with preimmune serum of the same rabbit (not shown).
The mSSL protein, initially named APMAP, had been reported to have a molecular
weight of approximately 47 kDa (Albrektsen et al., 2001). The reactivity of the
antiserum was repeated for the tissues used in this study. In addition bone marrow as an
immune organ, platelets and a stomach sample were tested (Figure 20).
37 kDa
25 kDa
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                              M        1         2         3         4          5         6         7
Figure 20: Antiserum against recombinant mSSL tested on different mouse
                   tissues:
                   1: platelets
                   2: bone marrow
                   3: brain
                   4: stomach
                   5: liver
                   6: kidney
                   7: heart
                   (labelled ~ 50 kDa protein indicated by stars; antiserum diluted 1:5000)
The antibody reacted against a protein of about 47 kDa in all tested mouse tissues,
which resembles the reported size of the mouse SSL protein (Albrektsen et al., 2001).
However, a large number of additional proteins were recognised as well, in many
instances with an even stronger intensity. I tried to improve the signal/noise ratio by
using higher dilutions of the tissue samples and the antiserum. Nevertheless the
detection of proteins did not change qualitatively. An affinity purification approach, in
which the 47 kDa-reactive subset of the antiserum was recovered from a nitrocellulose
membrane for incubation of a second Western blot, did not improve the results
considerably either (not shown).
250 kDa
150 kDa
100 kDa
  75 kDa
  50 kDa
  37 kDa
  25 kDa
undiluted samples
samples diluted 1:10
* *
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3.3   Use of a clot-specific antiserum in Galleria mellonella
It is difficult to isolate clot components from insects, mostly because the coagulation
process itself is quick and involves covalent cross-linking of proteins, which prevents
molecular characterisation. One way around this problem is to detect the constituents of
the coagulum rather indirectly using an antiserum. This was done using an antiserum
against a washed clot of G. mellonella produced by Dongmei Li (Li et al., 2002).
Briefly, a plasma clot from G. mellonella was formed in vitro around rabbit red blood
cells. This cell type was chosen for two reasons: They were not immunogenic for the
rabbit they were derived from, assuring specificity of the antiserum. In addition,
erythrocytes are covered with large numbers of glycoproteins, which provide a good
reaction matrix for a clot. The coagulum isolated this way was washed extensively prior
to injection to remove haemocytes and unspecifically bound haemolymph proteins.
I used this antiserum against the in vitro clot to characterise the Galleria haemolymph
coagulum. In a haemocyte preparation of Galleria the coagulum was visualised adjacent
to granular cells, underlining clot specificity of the antiserum. The only haemocytes
labelled by the anti-clot antibody were identified as granular cells (Figure 21).
Figure 21:Labelling Galleria mellonella haemocytes using a clot-specific antiserum
                  (top: phase contrast pictures, bottom: fluorescence microscope pictures)
      GR: granular cells, PL: plasmatocytes, OE: oenocytoids, SP: spherule cells;
                 white arrowhead indicates clot labelled with the antiserum (Li et al., 2002)
10 mm
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3.4   An assay for isolation of clot components in Drosophila
It would probably have been extremely time-consuming to isolate sufficient amounts of
haemolymph clots from Drosophila for the production of an antiserum as described for
G. mellonella. As an attempt to characterise new candidate clotting factors in
D. melanogaster, I therefore chose a different approach. Since the complete sequence of
the Drosophila genome was available, it was more promising to directly identify the
isolated proteins using mass spectrometry analysis instead of screening DNA-libraries
indirectly with an antibody. The pull-out method (see chapter 2.12) was expected to
represent a more specific way to identify functional clot components than by detection
with a polyclonal antiserum and allows additional controls. The general idea behind the
pull-out assay was to use paramagnetic beads for isolation of a detergent-resistant
haemocyte- and nuclei-free coagulum (Figure 7). The name “pull-out” was chosen to
stress the difference to conventional “pull-down” centrifugation methods. Proteins in
the retrieved sample were subsequently characterised molecularly by mass
spectrometry. The results presented here were published together with additional data in
Scherfer et al. (2004).
The haemolymph clotting ability of wild type Drosophila was assessed by two means,
the aggregation strength of the beads during sample preparation and the abundance of
certain proteins isolated from them. The bead aggregation strength was proportional to
the added haemolymph amount (Figure 22, upper row). Clot fibres bound to the beads
could be visualised using PNA. When larval haemolymph from domino mutants lacking
haemocytes (Braun et al., 1998) was added to the beads, bead aggregation was almost
absent (Figure 22, lower row).
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Figure 22: Haemolymph clotting followed by bead aggregation
                   upper row: addition of haemolymph from 0, 10 and 20 larvae to the beads
                   lower row: PNA: peanut agglutinin labelling of fibres between beads
                                               (beads: orange-brown, labelled clot fibres yellow-green;
                                                white arrow indicates PNA-labelled clot structures)
                                     dom/dom: domino homozygous mutant larvae
  dom/+: haemolymph from domino heterozygous larvae (control)
In order to test the specificity of protein binding to the beads, the supernatant including
unbound proteins was separated from the clumped beads and added to a new aliquot of
beads (“depletion assay”). This procedure was repeated several times. Proteins were
retrieved from the beads in each step and applied to a polyacrylamide gel (Figure 23)
together with the supernatant from the last binding reaction (“S”). The protein subset
isolated by this method was different from the total haemolymph composition with
many of the main Drosophila plasma proteins missing and some factors being strongly
enriched on the beads. Most of the bead-associated proteins could be depleted
completely from the haemolymph sample during the first binding reaction (Figure 23,
lane 1 compared to following lanes). The presence of hemolectin and tiggrin in these
samples correlated strongly with the intensity of bead aggregation. In contrast to other
isolated proteins, the apolipophorin subunits I and II continued to associate with the
paramagnetic beads after several reactions (Figure 23, open arrowheads).
PNA
0 10 20
dom/dom dom/+
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Figure 23: “Depletion assay” for proteins binding to the beads in vitro
                   (left picture: 10 % gel; right picture: 5 % gel)
                   1-4: successive binding reactions, S: supernatant after last binding reaction;
                   ++ strong  (+) very weak and – no bead aggregation;
        filled arrowheads: proteins that are depleted from the sample;
        open arrowheads: proteins that cannot be depleted (apolipophorin I and II);
                   hml: hemolectin, tig: tiggrin, lsp1c: larval serum protein 1m,
                   fbp1: fat body protein1, apo I and II: apolipophorin subunits I and II
The protein constituents of the clot bound to the beads were separated by gel
electrophoresis, major bands were cut out from a gel and characterised by mass
spectrometry (Figure 24; for method see chapter 2.14). It was not possible to redissolve
all shown proteins for mass spectrometry analysis. The molecular identity of other
proteins could not be determined by in silico analysis due to insignificant matches with
the database entries. Since transglutaminase is an important component of the clotting
system in several invertebrate and vertebrate groups, the transglutaminase inhibiting
substance monodansylcadaverine (MDC) was included in a sample (Figure 24). No
major inhibition of the protein binding to the beads was observed.
  1      2      3      4             S
++    (+)     -       -
apoII
apoI
tig
hml
lsp1c
hml
tig
15825
8280
fbp1
 1      2      3      4            S
++   (+)     -       -
CG
CG
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Figure 24: Putative clotting proteins isolated with the pull-out assay
       Peanut agglutinin was coupled to the beads in this experiment to
       improve clot protein recovery (gel performed by Christine Karlsson).
       Nevertheless, the same proteins bound even in the absence of PNA.
One of the characterised proteins was hemolectin, which previously had been implied in
coagulation and wound healing processes (Goto et al., 2001, 2003). The same working
group also produced an antiserum against hemolectin, which I used in
immunofluorescence experiments to show that hemolectin is a major compound of the
clot fibre structures (not shown). The clot-labelling lectin PNA (Figure 22) exclusively
detected hemolectin in the protein mix from the pull-out on a Western blot (Figure 25).
CG 15293
  50
  37
  25
250
150
100
  75
hemolectin (CG 7002)
apolipophorin I (CG 11064)
tiggrin (CG 11527)
larval serum protein 1c (CG 6821)
apolipophorin II (CG 11064)
CG 15825
prophenoloxidase (CG 8193)
fat body protein 1 (CG 17285)
(peanut agglutinin)
CG 8280 (elongation factor 1a48D)
fat body protein 1 (CG 17285)
     MDC
   +      -
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                                  Coomassie  PNA
                                                
Figure 25: Peanut agglutinin exclusively recognises hemolectin from proteins
                   isolated with the pull-out assay (5 % SDS-polyacrylamide gel)
                   left: Coomassie-stained gel, right: PNA-labelling on blot;
                   black arrowhead indicates position of hemolectin
Tiggrin, an extracellular matrix protein, was found in the preparation in two forms with
slightly different molecular masses. These two forms probably reflect two novel
isoforms or glycosylation states of the protein. No other extracellular matrix proteins
were identified amongst the proteins isolated with the pull-out assay.
The apolipophorin subunits I and II of Drosophila “high-density lipophorin” (HDLp,
originally described as “retinoid- and fatty-acid binding glycoprotein”; Kutty et al.,
1996) continued to associate with the beads in the depletion test (Figure 23). Therefore
it is possible that they do not represent specifically bound clotting proteins. An
alternative explanation will be discussed.
The retrieved peptides from the characterised prophenoloxidase match best with the
prophenoloxidase CG 8193 (judging from the matching profile in the Mascot database).
To date there are no known homologues to the uncharacterised product of gene
CG 15825 in any other species including insects. A decreased amount of this protein
was retrieved from the beads after transglutaminase inhibition with MDC (Figure 24),
but was not followed up later.
To functionally confirm an involvement of hemolectin in clotting, I tested the effects of
RNA interference (RNAi)-mediated down-regulation of hemolectin on the aggregation
hemolectin
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ability in the assay. Crossing a UAS-hml RNAi line to an Actin5C-Gal4 strain, dsRNA
production was expected to be induced strongly and ubiquitously in all cells starting
from early development. The RNAi crosses were viable and did not show any
morphologically visible defects. The addition of haemolymph from these larvae to
beads did not cause a normal aggregation reaction. Haemolymph from the RNAi crosses
contained haemocytes, in which the regulation of clotting seemed to be impaired, since
an extracellular clot meshwork was missing (Figure 26).  Furthermore the haemocytes
included numerous oversized granules. This altered cell morphology was similar to
haemocytes collected in anti-coagulation buffer lacking calcium ions and including
EDTA (personal observation). It should be highlighted that coagulation did occur even
after hemolectin RNAi knockdown, albeit with much delay and less extent.
Figure 26: Clot formation and haemocyte morphology after hemolectin RNAi (a)
                   and in wildtype larvae (b); arrowheads: large granular inclusions.
The RNAi-knockdown of hemolectin was confirmed by a SDS-gel of the proteins
derived from a pull-out assay with knockdown larvae. A substantial decrease of
hemolectin could be demonstrated, while the amounts of the other characterised
proteins did not seem to be changed (data not shown). Bead aggregation was strongly
impaired in haemolymph from hemolectin RNAi larvae (Figure 27, upper row).
Haemolymph prepared as a control from the offspring of the same parental lines, but
lacking the actin promoter-driven Gal4 gene (instead bearing a balancer chromosome),
aggregated the beads comparable to control haemolymph (Figure 27, lower row).
a b10 mm
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Figure 27: Bead aggregation is lacking in hemolectin RNAi larvae
                   (light microscopy pictures, magnification: left 10 x, right 40 x)
3.5 Regulation of haemolymph coagulation - preliminary results
Putative clotting factors were characterised by the pull-out assay as well as by 2D-gel
comparisons of haemolymph samples before and after clotting (Karlsson et al.,
unpublished results). The functional significance of most of these proteins is still to be
elucidated. Furthermore it is still widely unclear, how the different factors interact with
each other. Even if it is too early to construct a detailed reaction scheme of the process,
data from some pilot experiments might give hints to certain features of the system.
In order to confirm a reported induction of hemolectin transcription during development
and after pricking (Goto et al., 2001), a RT-PCR reaction was performed with RNA
samples from pricked and non-pricked animals (see chapter 2.16). I aimed to re-
investigate the induction kinetics of hemolectin more carefully by adding additional
time points. Furthermore the infection studies in the mentioned report had only been
performed on adult flies. The use of larvae for clotting studies in our laboratory
prompted me to additionally check the effect of poking in this developmental stage.
Contrary to the previously published RT-PCR experiment, hemolectin was neither up-
regulated during development nor in response to needle-pricking in the present study
(Figure 28).
RNAi-larvae:
UAS-RNAi hml
x Act5C-Gal4
Control larvae:
UAS-RNAi hml
x CyO-GFP
(from the balancer
chromosome)
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                          primers for RP49 (control)                  primers for hemolectin
                       1hC   1h     6h   12h  24h  24hC  M  1hC   1h    6h    12h   24h  24hC
feeding
larvae
wandering
larvae
adult flies
Figure 28: RT-PCR with primers for hemolectin (right) before and after poking
                   different developmental stages of Drosophila with a fine tungsten needle
                   C: non-poked animals kept under the same conditions as a control;
                   1h, 6h, 12h, 24h: time points after poking (induction time)
       left side of gel pictures: control primers for ribosomal protein 49 (RP49)
The influence of several putative coagulation inhibitors was tested for a possible impact
on the composition of the protein subset isolated with the pull-out assay (Figure 29).
The differences in the protein amounts in response to chemicals and even intra-sample
variations turned out to be high. In general, a decrease of lower molecular weight bands
like CG 15825 and tiggrin (Figure 29, arrows) correlated with the appearance of higher
molecular weight complexes and a larger amount of hemolectin retrieved. The
combinatory effect of all putative effectors led to a strong inhibition of this cross-
linking (Figure 29, lane 7), although this effect was not always as intense as shown
here. Nevertheless I decided to use Ringer solution with 20 mM EDTA and lacking
calcium for samples simulating clotting inhibition to keep the reaction buffer as
unmodified as possible.
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       M       1        2       3       4        5       6       7
                                
     250 kDa
     150 kDa
100 kDa
        75 kDa
        50 kDa
        37 kDa
  25 kDa
Figure 29:  Addition of putative anticoagulants to the pull-out reaction
1: Drosophila Ringer – PTU; 2: Ringer + PTU;
3: Ringer – calcium / + 20 mM EDTA; 4: Ringer + 1 mM ascorbic acid;
5: Ringer + 5 mM MDC; 6: Ringer + 0,1 % natrium azide;
7: Ringer – calcium; + EDTA/PTU/ascorbate/MDC/azide
(haemolymph from 20 larvae each; white arrowhead indicates tiggrin;
                       black arrowhead shows position of CG 15825)
Since a mutant for serpin-27A (a serine protease regulating the phenoloxidase cascade)
had become available, we tested larvae of this stock for a possible haemolymph
coagulation defect. In addition a stock with a double mutation for serpin-27A and Black
cells (kindly provided by Dr. Bruno Lemaitre) was used to check for the in vitro clotting
ability. While haemolymph from both single mutants for Black cells and serpin-27A
retained its ability to aggregate beads, the combined effect of both mutations caused a
clear impact (not shown, comparable to Figure 22, domino). More intriguingly, this
observation was reflected by the amount of hemolectin retrieved from the beads
compared to the single mutants or the wildtype larvae (Figure 30).
                            1        2         3         4        5
250 kDa
150 kDa
100 kDa
Figure 30: Comparison of pull-
out retrieved proteins from
mutants (5 % SDS-gel)
   1   wildtype
   2   molecular weight standard
   3   Black cells
   4   Black cells/serpin-27A
   5   serpin-27A
Haemolymph from 30 instead of
20 larvae was used for the double
mutant (4) to compensate for a
smaller amount of haemolymph.
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4     Discussion
4.1   Studies on localisation and functions of hemomucin
The hybridisation binding pattern of hemomucin probes during embryonic development
(Figure 9) together with already published expression data from larvae and adult flies
(Theopold et al., 1996, 2001) suggests broad biological functions for hemomucin. These
possibly include hardening and sclerotisation or an involvement in immune reactions by
pathogen immobilisation. Trachea, fore- and hindgut of the embryos, the peritrophic
matrix of adults and eggshells are all sites of hardening processes. The also labelled
larval salivary glands secrete sticky proteins prior to pupation that aid to attach the
larvae to surfaces by forming a solidifying glue. Hemomucin may contribute to all these
processes by aggregating to protein oligomers, since it tends to dimerise (Theopold et
al., 1996). The galactose and N-acetyl-galactosamine glycodeterminants of hemomucin
might cross-link with each other, possibly by endogenous lectin activity. Interestingly
the pattern of hemomucin expression is similar to the one obtained by labelling of the
embryo with wheat germ agglutinin (Callaerts et al., 1995).
Alternate to a sclerotising function, hemomucin might bind and immobilise bacteria on
organ surfaces to prevent infections from spreading further into the haemocoele. Cross-
linking was proposed to occur between hemomucin and sugar determinants on bacterial
cell surfaces catalysed by haemolymph lectin activity (Theopold et al., 1996). It is
intriguing, that most hemomucin expression sites as embryonic trachea, fore- and
hindgut, adult peritrophic matrix and egg surfaces are potentially exposed to
microorganisms. Both hypotheses point towards a dual function of hemomucin in
immunity and development.
Transcripts of the second strictosidine synthase-like gene CG 11833 are present in the
trachea, while tissue labelling is different from the one with the hemomucin probe
(Figure 10). In contrast to hemomucin the CG 11833 protein does not include a mucin
domain but consists only of the strictosidine synthase-like sequence. The similar
binding of the probe to the trachea may therefore reflect a function of the SSL-domain
in this specific organ.
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Using the hemomucin antiserum for detection on a Western blot (Figure 8), it could be
shown that the membrane protein hemomucin is released from the haemocytes during
clotting, probably mostly on microparticle surfaces. Detection of hemomucin with HPL
on membranes does not lead to a sufficient signal on Drosophila haemocytes. On this
membrane the release of the protein from the cells into the haemolymph can be seen
clearly (Figure 8). HPL does not recognise hemomucin in the cell fraction either,
probably due to the fact that the membrane was already incubated before with the
antiserum, which might have blocked all hemomucin binding sites. However, the lectin
shows a quite good labelling for hemomucin in mbn-2 cell samples on Western blots
(Figure 13 and Theopold et al., 1996). The strong HPL signal on haemocyte monolayer
preparations in contrast to the weak recognition on Western blots might be explained by
HPL binding to other hemocyte membrane molecules such as N-acetyl-galactosamine
determinants of glycolipids, which are not recognisable on the Western blots (Dr. Ulrich
Theopold, personal communication).
Microparticle formation in the Drosophila cell culture in reaction to ionophore
treatment (not shown) correlated well with the depletion of hemomucin from haemocyte
membranes (Figure 11). Microparticles are often found attached to haemolymph clots
and may thus induce clotting analogous to vertebrate microparticles. It seems likely that
hemomucin is actively shed into microparticles. The protein might therefore be a
functional component of the particle surface and leads to stimulation of clotting. It is
interesting to note that not all mbn-2 cells were sensitive to ionophore treatment and
that those who were not showed a lowered lectin labelling already prior to addition of
the ionophore (Figure 12). This could be interpreted in different ways: It is possible that
these cells released particles together with hemomucin prior to the start of the
experiment and could thus be characterised as non-reactive altered cells. However, it
cannot be excluded that there might in fact be separate subpopulations in the cell culture
that differ in their hemomucin content. It is tempting to speculate that this reflects the
differential reaction of two haemocyte classes in vivo. Finally it is possible that this non-
reactive cell population represents cells right after cell division with a thus lowered
capacity for protein synthesis. Unfortunately it might be hard to morphologically
characterise a difference between these two haemocyte groups in D. melanogaster,
since this species predominantly contains plasmatocytes.
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Knock-down of hemomucin in mbn-2 cells by RNAi proved to be successful
(Figure 13). No obvious changes in cell morphology and behaviour could be observed
and HPL membrane labelling was comparable to untreated cells. This observation might
be explained by a slow turnover rate for hemomucin in the membrane, while
intracellular hemomucin production would already be impaired, leading to a lower
protein level in the electrophoresis sample. Hence it would be interesting to investigate
the immune effect of hemomucin RNAi in vivo in a transgenic Drosophila fly line with
an inducible promoter for a dsRNA hairpin construct. Furthermore the study of putative
functions of the protein during development would be feasible in such flies. I aimed to
generate a transgenic fly stock for hemomucin RNAi in vivo. However, this approach
was finally not successful. As shown in Figure 15, the efficacy of Sfi I restriction and/or
the first ligation was quite low. It has long been recognised that some restriction
enzymes do not cut optimally at the ends of a PCR fragment (Kaufman & Evans, 1990).
Nevertheless the study of Kennerdell & Carthew (2000) demonstrates that the technique
used here (see chapter 2.10) is in general feasible with the chosen restriction enzymes. It
is possible that the experimental conditions used did not favour a successful ligation. A
number of additional difficulties connected with the method by Kennerdell & Carthew
(2000) were pointed out later. Importantly transgenes with an inverted repeat on a
plasmid exhibit a comparably weak stability in E. coli cells (Lee & Carthew, 2003).
This finding is in agreement with the low occurrence of successful transformations
obtained in the present study. Lee & Carthew (2003) therefore proposed to stabilise the
plasmid by insertion of a longer intron-based spacer sequence between the inverted
repeated sequences. After in vivo transcription this spacer is spliced out leading to a
“loop-less” double-stranded RNA molecule. This technique led to considerably better
results and is commonly used today, but was only reported towards the end phase of the
present work and thus not used. A transgenic fly line for hemomucin RNA interference
is now available in our group (kindly provided by Dr. Bruno Lemaitre) and will help to
elucidate the probably various functions of hemomucin in vivo. Another possibility to
address the putative roles of hemomucin in immunity and development would have
been the injection of the in vitro transcribed dsRNA into Drosophila embryos. Due to
time limitations of the project this approach was not followed up either. A general
problem is that injections include the generation of a wound and thus analysis of
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clotting defects in such animals is ambiguous. In summary, a specific function has yet
to be assigned to hemomucin. It is likely that its ability to bind sugars on pathogen
surfaces and to form oligomers is crucial for its biological role. A pro-inflammatory
reaction might be regulated by association of hemomucin with lipophorin (Theopold &
Schmidt, 1997). In the same study it was also suggested that putative lipid-binding
properties of hemomucin (due to a large amount of hydrophobic amino acid residues in
its sequence) may regulate association of hemomucin with lipophorin. Interestingly, the
latter property is probably exploited by a parasitoid wasp to block an immune response
by recruiting host lipophorin to wasp hemomucin deposited on eggs (Kinuthia et al.,
1999).
According to this model, hemomucin may be a functional component of the clot matrix
accessible to both cross-linking by lectins and regulative blocking by lipophorin (see
also chapter 4.6). Hemomucin homologues are present in two lepidopteran species
(Kotani et al., 1995, Scholz, 2002) and in the mosquito A. gambiae even SSL-proteins
with similarity to both Drosophila SSL-proteins (with and without the mucin domain)
are conserved (gene accession numbers “XP_309617” and “XP_321354”,
http://www.ncbi.nhlm.nih.gov). The fact that hemomucin is induced during Plasmodium
infections of Anopheles mosquitoes (George Dimopoulos, personal communication)
strengthens the suggestion that hemomucin is a factor involved in insect immune
reactions.
4.2   Recombinant expression of the mouse SSL protein in E. coli
        for production of an antiserum
An antiserum against a recombinantly expressed mouse SSL protein (mSSL) was
raised. This mSSL-protein produced in E. coli was even recognised by the antiserum
against the SSL-domain of hemomucin (Figure 18), confirming that the EST was coding
for the right sequence. The anti-mSSL antiserum had a considerably good specificity for
the recombinantly expressed protein from E. coli cells (Figure 19). The mouse SSL
protein of about 47 kDa was initially described as APMAP, “adipocyte plasma
membrane-associated protein” (Albrektsen et al., 2001). In this study expression of the
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protein in heart, brain, liver and kidneys of mice has been demonstrated. Nevertheless
the polyclonal antiserum raised in both rabbits during the present work predominantly
recognised a large number of additional mouse proteins (Figure 20) and thus appears to
cross-react non-specifically. An affinity purification of the anti-mSSL antiserum from
the nitrocellulose membrane did not improve the results considerably. Therefore the
signals retrieved from the mouse tissues have to be discussed with caution. Since the
mSSL protein includes no mucin domain like hemomucin (Albrektsen et al., 2001), a
cross-reaction with other serine- and threonine-rich sequences can be excluded. It is
possible that the mSSL protein is strongly N-glycosylated in vivo, as suggested by
Albrektsen et al. (2001). The antibodies are likely to be directed against the unmodified
amino acid backbone of the recombinantly produced protein which is buried under
bulky carbohydrate groups in the native mouse protein. Other post-translational
modifications might be lacking in the E. coli cells as well. This may explain, why
labelling of the recombinantly produced mSSL protein with the antiserum is quite
unsatisfying. Unfortunately the weak binding specificity of the antibody produced in the
present study did not allow any further experiments. We also obtained an mSSL
antiserum produced by another group (Albrektsen et al., 2001), which did not show
sufficient binding in Western blot analysis either. This may indicate a general problem
to create an antiserum against the mSSL protein.
Interestingly a strong expression of the human SSL protein has been observed in human
brain and immature immune organs (Ulrich Theopold, unpublished results). It remains
therefore tempting to investigate the expression of mSSL in bone marrow and platelets
of mice. Plant strictosidine synthases are important for alkaloid biosynthesis and
vertebrate brains are target organs for alkaloids interfering with dopaminergic synapses.
However, in situ hybridisations of mouse brains with an mSSL RNA probe did not lead
to labelling of dopaminergic regions (Christine Karlsson, personal communication). In
summary, the functions of SSL proteins in vertebrates remain enigmatic and will be an
interesting research subject in the future. An additional fact points towards the
importance of SSL proteins in immunity: Most sequenced bacterial genomes contain no
SSL homologs. However, Pseudomonas aeruginosa, a facultative bacterial pathogen of
plants, flies and man, seems to have acquired an SSL gene through horizontal gene
transfer from one of the vertebrate genes, with which it shares the highest similarity
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4.3   Use of a clot-specific antiserum in Galleria mellonella
Initially we aimed to molecularly characterise clot components in G. mellonella, since
the morphology of haemolymph coagulation is well described for this insect species. As
a part of this project I used an anti-clot antiserum (Li et al., 2002) in immune
fluorescence microscopy investigations of Galleria haemocyte preparations. The
antiserum bound strongly to extracellular clot structures as well as attached
microparticles (Figure 21 a). From the five described haemocyte types of G. mellonella
only granular cells were labelled (Figure 21 b and c). This is in agreement with earlier
morphological studies showing that the granular cells of lepidopterans are the
haemocyte type involved in primary clot formation by degranulation of fibrous material
(Bohn, 1986, Rowley & Ratcliffe, 1976). Hence the antiserum can be considered an
interesting tool to identify clotting factors of G. mellonella. Further results obtained
with the same antiserum in a library screen (done by Dongmei Li, Li et al., 2002)
provided insights into the identity of the constituents of the Galleria haemolymph
coagulum. While recognition of a mucin-like sequence by the antiserum once more
highlighted the importance of glycoproteins in coagulation, prophenoloxidase-specific
antibodies highlighted a connection between these enzymes and the clotting process that
had been proposed earlier. The detection of a hexamerin in the clot is interesting, since
an arylphorin-like gallysin from G. mellonella was shown to lyse erythrocytes and kill
Gram-negative bacteria (Beresford et al., 1997). An immune function for hexamerins
was further demonstrated for other insect species, including inhibition of degranulation,
encapsulation and nodule formation in Pseudaletia separata armyworm larvae
(Hayakawa, 1994). Several lipophorin expression clones were found in the library
screen. Lipophorin became incorporated into the Galleria clot quite late during the
ongoing coagulation process compared to other proteins (Li et al., 2002). Lipophorin
involvement in haemolymph coagulation was reported earlier for cockroaches (Barwig,
1985) and locusts (Duvic & Bréhélin, 1998) and will be discussed in detail in
chapter 4.4. Finally a large number of antibodies recognised a so far uncharacterised
protein with little similarity to the a-crystallin family (MacRae, 2000). Interestingly
crystallins are known to differ considerably in their sequence, but not in their
hydrophobicity, they easily self-aggregate and are cross-linking targets for
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transglutaminases (de Jong, 1993, Shridas et al., 2001). The a-crystallin-like protein
might therefore be one of the transglutaminase substrates in Galleria, supported by the
presence of numerous cross-linkable lysine residues in its amino acid sequence.
In general, the production of an antiserum against an in vitro formed clot proved to be a
successful approach and may be used in further comparative studies in different insect
orders. Nevertheless, there are limits to conclusions concerning the in vivo situation in
the insect. It is likely that parts of the native clot are of cellular origin and could thus not
be retrieved, since cell-free haemolymph was used for antiserum production.
Furthermore it is possible that certain clotting factors already precipitated prior to
contact with the erythrocyte membranes and are no longer available for the in vitro clot.
Since no inhibitors of phenoloxidase activity like PTU were added to the in vitro
clotting reaction used for antiserum production, it cannot be excluded that some of the
antibodies actually recognise phenoloxidase substrates in G. mellonella and not only the
initial clot components. Further restrictions of the anti-clot antiserum will be pointed out
in chapter 4.5.
4.4 A novel assay for isolation of clot components in Drosophila
In search for a quick and inexpensive method to isolate a haemolymph clot from
D. melanogaster I used paramagnetic beads, which were passively incorporated into the
forming coagulum and facilitated separation of the clot from haemocytes and cell debris
(Figure 7). In addition the strength of bead aggregation seemed to reflect in vitro
clotting ability in a reproducible manner (Figure 22). The clot proteins characterised by
mass spectrometry clearly showed a composition different from the total haemolymph
and were depleted from the buffer quite quickly in subsequent binding reactions
(Figure 23), strengthening their putative role in coagulation. A remarkable feature of
many of the pull-out retrieved proteins (Figure 24) like e. g. hemolectin and tiggrin is a
relatively high molecular weight. In is interesting to note that non-crosslinked protein
gels form more likely from large protein monomers that tend to entangle already at low
concentrations of only one percent or less (Doi & Edwards, 1988).
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Hemolectin (hml), the protein isolated from the beads in the highest quantity, was
furthermore labelled by peanut agglutinin in a Western blot reaction (Figure 25). This
was in accordance with the detection of PNA-reactive proteins in the coagulum in
immunofluorescence studies (Figure 22), showing that hemolectin is part of the fibrous
clot. An antiserum against hemolectin (kindly provided by Dr. Akira Goto) confirmed
this conclusion in immunohistochemical clot preparations (not shown), strongly
labelling the fibres of the coagulum. There is at least one additional PNA-reactive
protein “gp150” (gene name “I71-7”) present in the total haemolymph, which
presumably is involved in the clotting process as well (Korayem et al., unpublished
results). This protein gp150 could not be retrieved with the pull-out assay, probably due
to its rapid cross-linking in the free haemolymph prior to potential binding to the bead
matrix. In the lepidopteran insect Manduca sexta the PNA-reactive proteins are present
in granular cells throughout development (Nardi, 2004). Intriguingly PNA-labelling
even increased in the granules of this haemocyte subtype in M. sexta pupae compared to
larvae (Beetz, 2002). In agreement with this observation the hemolectin homologue in
M. sexta, hemocytin, is expressed in granular cells (Scholz, 2002). These results
underline a possible immune function for PNA-reactive proteins in insects and putative
endogenous haemolymph galactose-specific lectin activities that may transmit the signal
to other components of the immune system.
Interestingly, hemolectin displays high similarity to vertebrate von Willebrand factor
and had recently been proposed to influence the wound healing ability of larvae (Goto
et al., 2003). The impaired bead aggregation after hemolectin RNAi (Figure 27)
possibly reflects a defect in a primary step of haemolymph coagulation in insects,
possibly resembling primary haemostasis in vertebrates. Intriguingly the presented
change in haemocyte morphology (Figure 26) is reminiscent of an impairment of
platelet degranulation in patients with von Willebrand disease (VWD). With an
incidence rate of about 1 % in the whole population, VWD represents the most common
inherited bleeding disorder in men (Sadler, 1998, Triplett, 2000). In vertebrates vWF is
constitutively present in the blood and endothelial cells, even in preformed high
molecular weight polymers. Binding to wounded subendothelium and shear stress leads
to a conformational change of the protein that further stimulates protein aggregation
(Sadler, 1998). Similarly insect clotting may require a concentration threshold or
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conformation of hemolectin that causes haemocytes to degranulate at wounds and
release intracellular clotting factors. Even in hemolectin RNAi knockdown larvae
coagulation finally occurred, though after prolonged time periods, similar to the
situation in patients with vWF mutations.
Hemolectin is a large protein of 427 kDa with a number of conserved domains
(Figure 31) that may facilitate interactions with haemocytes and the wound edges or
with other clot proteins. Most intriguingly, in Drosophila hemolectin (Goto et al., 2001)
as well as in hemocytin of B. mori (Kotani et al., 1995) and of M. sexta (Scholz, 2002)
there are several domains with similarity to vertebrate von Willebrand factor (vWF).
Five copies of a vWF D-like domain, which accounts for self-aggregation of vWF
(Mayadas & Wagner, 1992) are present in hemolectin. In addition four short sequence
stretches resemble the vWF C domain, which is also important for protein
oligomerisation. Two hemolectin domains display high similarity to vertebrate
coagulation factor 5/8 and are also known as discoidin domains. Members of the
discoidin family were initially described to bind galactose, but are even known to
recognise phosphatidylserine and collagen and promote cell aggregation and adhesion
(Baumgartner et al., 1998). This broad spectrum of putative ligands raises the possibility
that association of a binding partner to the discoidin domain of hemolectin may change
its conformation and activate the clotting process. A low-density lipoprotein (LDL)
receptor domain may bind lipophorin at later steps of clotting (see below). The C-
terminal cystine knot-like domain probably catalyses the initial dimerisation of
hemolectin prior to further multimer formation (Goto et al., 2001). Two N-terminal
epidermal growth factor (EGF)-like domains and a central peritrophin A-like chitin
binding domain might enable hemolectin to bind to the wound site and thereby ensure a
localised clotting reaction. Even an N-terminal sequence with weak but significant
similarity to laccases can be recognised. Laccases are cross-linking enzymes with
phenoloxidase-like activity, which in this case may be specialised for the requirements
of clotting. The presence of an autocatalytic cleavage site GDPH similar to human
mucins (Lidell et al., 2003) in the amino acid sequence suggests a so far undiscovered
activation mechanism for hemolectin.
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Figure 31: Domain structure of Drosophila hemolectin (CG 7002)
                   (including domains identified by Goto et al., 2001)
                   Additional domain similarities were identified with NCBI conserved
                   domain search (http://www.ncbi.nhlm.nih.gov) and SRS Interpro Entry
                   Search (http://srs.ebi.ac.uk). The small sequence patterns RGD, CGLG and
                   GDPH were detected by manual search. The amino acid (AA) locations of
                   The motifs are noted in brackets. In cases where different domain lengths
       were found by the used programs, the broadest motif borders are given here.
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Tiggrin is an extracellular matrix protein expressed in haemocytes, fat body and other
tissues. It is also present at muscle attachment sites of Drosophila (Fogerty et al., 1994),
where it interestingly colocalises with lipophorin (Kutty et al., 1996). No orthologue of
tiggrin is known from other insect species to date. The amino acid sequence of the
protein includes an RGD peptide that mediates integrin contacts of muscle cells with the
tendon matrix, thereby confering stability and elasticity to pre-existing muscle-
epidermis contacts (Bunch et al., 1998). In vertebrates the fibrillar collagen receptor
a1b1-integrin is involved in wound contraction through myofibroblasts (Racine-
Samson et al., 1997). In insects there is no fibrillar collagen (Hynes & Zhao, 2000). It is
thus intriguing to speculate that similarly tiggrin may contribute to clot strength by
interaction with haemocyte surface integrin aPS2bPS, so that the scar can withstand
body movements of the wounded larva. If this proves to be the case, tiggrin may even
be considered a functional analogue of vertebrate fibronectin, since no sequence coding
for a fibronectin is present in the Drosophila genome. A possible role in immunity is
also supported by the observation that tiggrin is induced after injury (Irving et al.,
2001). A general putative role for integrin binding sites in clotting proteins will be
discussed later.
Other products of injury-induced genes isolated with the pull-out assay include the
proteins encoded by the genes CG 15825 and CG 15293 (De Gregorio et al., 2001).
Both gene products show no significant homology with any protein in the databases and
are induced with slow kinetics. This expression pattern might be expected for genes
involved in clotting and is similar to the one of mosquito genes induced by aseptic
wounding (Dimopoulos et al., 2002). Additional support for a role of the CG 15825
protein in clotting is added by recent results which show that it is a substrate for
transglutaminase (Karlsson et al., unpublished results). There is evidence for an
involvement of the Toll pathway in the induction of both CG 15825 and CG 15293
(De Gregorio et al., 2002).
Additional proteins isolated with the pull-out assay are larval serum protein 1 gamma
(lsp1c), which is one of the major haemolymph proteins in third instar larvae of
Drosophila (Kanost et al., 1990) and fat body protein 1 (fbp1), which has been shown
to bind lsp1c (Burmester et al., 1999). Fbp1 was detected in two fragments of 69 and
49 kDa. Both lsp1c and fbp1 belong to the hexamerin family, a group of haemolymph
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storage proteins (Burmester et al., 1999). It is possible that hexamerin binding to the
beads is a non-specific interaction resulting from the high concentration of these
proteins in the haemolymph. However, both hexamerins and in particular lipophorin
have been implied in clotting of Galleria haemolymph earlier (Li et al., 2002). Hence it
seems plausible that haemolymph coagulation, which has to be fast and efficient, relies
at least partly on the recruitment of some abundant haemolymph proteins.
The retrieved fragments of prophenoloxidase CG 8193 include peptides from the N-
terminal region and the protein sequence does not possess a predicted cleavage site.
This indicates a non-proteolytic activation mechanism of the enzyme. Possibly binding
of the enzyme to the clot or simply crossing a concentration threshold at the wound site
leads to a conformational change that stimulates phenoloxidase activity. The
prophenoloxidase CG 8193 may fulfil specialised haemostatic functions in Drosophila
haemolymph, since its haemolymph levels also differ considerably between clotted and
not clotted samples (Karlsson et al., unpublished results). Since coagulation occurs even
in the absence of haemolymph phenoloxidase activity in Black cells mutant larvae
(Scherfer et al., 2004; Figure 2), it can be excluded that clotting is dependent on this
cross-linking step. Even the composition of a Black cells haemolymph clot isolated with
the pull-out assay or transglutaminase inhibition by MDC did not differ from the protein
pattern in wildtype larvae. However, phenoloxidase and transglutaminase might very
well harden the clot and apply stability to it, preventing its destruction through larval
body movements. It remains an open question, if phenoloxidase and transglutaminase
activities complement each other or if they represent subsequent reactions. It is
interesting to note that synthetic melanin was recently reported to effectively inhibit
vertebrate transglutaminases (Ikura et al., 2002).
CG 15825, tiggrin and fbp1 contain a large number of glutamine residues (9, 12 and
14 % respectively). The average amino acid composition of proteins includes 4 %
glutamines (McCaldon & Argos, 1988), thus an increased proportion may well reflect a
functional feature of the mentioned proteins. Additional factors incorporated in the
haemolymph clot like hemolectin, CG 8280, lsp1c and lipophorin display elevated
levels of lysine residues. Glutamine-rich proteins self-associate easily to form
aggregates, a pathological feature observed in human prion diseases (Michelitsch &
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Weissmann, 2000) and neurodegenerative disorders like Chorea Huntington (Masino &
Pastore, 2002). Even transglutaminase activity is involved in the progress of these
diseases (Violante et al., 2001). Since the glutamine residues occur through CAG
nucleotide expansion in the mentioned cases, the non-clustered glutamines in putative
insect clot proteins are probably not acquired through the same mechanism. However,
glutamines together with lysines are also substrates for the terminal cross-linking of clot
proteins by transglutaminase in vertebrates. In Drosophila CG 15825 and lipophorin
have already been shown to be transglutaminase substrates (Karlsson et al., unpublished
results). The transglutaminase inhibitor MDC caused a lowered level of CG 15825 in
the clot. An “early stage encapsulation protein” from the beetle Tenebrio molitor (Cho
et al., 1999) even includes 17 % glutamines and might also be a clot protein.
Besides tiggrin, hemolectin (see Figure 31), fbp1 and transglutaminase of D.
melanogaster also contain an RGD motif. A KGD integrin-binding site from crayfish
protein peroxinectin (Johansson, 1999) stimulating encapsulation reactions in vitro
(Kobayashi et al., 1990) is as well present in Drosophila annexin IX and lipophorin.
Hemolectin, fbp1, lsp1c and CG 15293 contain an additional cell-adhesion motif LRE
(Yamada, 1991), tiggrin two copies. Interestingly clustered RGD-peptides are focal
adhesion sites for stress fibre formation (Maheshwari et al., 2000). A point mutation of
the RGD motif to AGD in a recombinant human vWF protein caused a total loss of
binding to glycoprotein IIb/IIIa (Jumilly et al., 2001), underlining the importance of this
peptide for the clotting process in vertebrates. Vertebrate integrin antagonists called
disintegrins contain a RGD or KGD motif and are inhibitors of platelet aggregation
(Andrews & Berndt, 2000). Similarly, the high abundance of the mentioned cell
adhesion patterns RGD, KGD and LRE in factors implied in insect haemolymph
coagulation probably reflects a secondary function of the clot, namely the attraction of
flattening lamellocytes that express high levels of integrins (Irving et al., 2003) and
form capsules around foreign objects and organisms. Moreover it was suggested earlier,
that RGD-containing haemolymph proteins may promote attachment of insect
haemocytes to wounds (Lackie, 1988).
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Both subunits I and II of the Drosophila lipophorin (“retinoid- and fatty-acid binding
glycoprotein”; Kutty et al., 1996) were present in the pull-out derived clot.
Apolipophorins are multifunctional proteins with the ability to store and transport large
amounts of lipids and represent a major constituent of insect haemolymph (Blacklock &
Ryan, 1994). Earlier studies proposing apolipophorin as the clotting protein in several
insect species may therefore be explained in two different ways: Either the sheer
amount of protein in the plasma (Kanost et al., 1990) causes unspecific binding to the
coagulum, as it might be the case for lsp1c and fbp1.  Alternatively this association is
due to a functional binding, which may for example be achieved through the low
density lipid protein receptor domain of hemolectin. Lipophorin is a transglutaminase
substrate in Drosophila (Karlsson et al., unpublished results). In Galleria it binds to the
coagulum quite late during its formation, as shown with the anti-clot antibody (Li et al.,
2002). The protein is involved in several aspects of insect immunity: It inhibits
haemocyte spreading in vitro (Coodin & Caveney, 1992, Mandato et al., 1996) and was
successfully used to prevent cell aggregation in H. cecropia (Lanz-Mendoza et al.,
1996). In addition lipophorin blocks proteolytic prophenoloxidase activation (Duvic &
Bréhélin, 1998), induces reactive superoxide production (Arakawa et al., 1996) and
assists in LPS detoxification from the haemolymph (Kato et al., 1994). Eggs of a
parasitoid wasp block an effective immune response by binding host lipophorin
(Kinuthia et al., 1999). If a protein with such numerous inhibitory functions is
incorporated into a clot, this might lead to negative feedback regulation for several
immune reactions at the wound. This hypothesis is also strengthened by the slow
binding kinetics of lipophorin to the G. mellonella clot. The inhibitory mechanism may
be achieved by competitive clustering on integrin binding sites through the KGD motif
or blockage of immune-stimulating phospholipids.
Conversely, a lower molecular weight insect lipoprotein, apolipophorin III, stimulates
phagocytosis and induces immune genes in response to infection (Wiesner et al., 1997),
long after clotting has reached its end. Apolipophorin III was proposed to possess an
inflammatory activity by associating with lipids and apolipophorin I and II (Dettloff et
al., 2001). This complex, also called “low-density lipophorin” (LDLp) is not
constitutively present in insect haemolymph (Soulages & Wells, 1994). Under normal
conditions larval apolipophorin III does not contain any lipids (Cole & Wells, 1990).
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The occurrence of LDLp in moulting larvae of M. sexta might be essential for an
activated immune state during this life period due to a potentially higher susceptibility
of the integument to infections (Engler et al., 1996). Hemagglutinating properties of
apolipophorin III were ascribed to recognition of cellular glycolipids resembling
bacterial LPS (Chung & Ourth, 2002), since interaction with glycoproteins could be
excluded (Iimura et al., 1998). Moreover, this binding reaction seems to possess some
specificity, since only certain LPS types added to the in vitro reaction interfered with
cell aggregation (Iimura et al., 1998). Interestingly the immune-induced serine protease
scolexin from M. sexta binds to LDLp (Dettloff et al., 2001). This observation is in
good agreement with the reported glucose-specific hemagglutinating activity of this
protein (Minnick et al., 1986), which could provide an additional mechanism to
immobilise microorganisms at the wound site. On basis of the summarised data I
propose a model for the involvement of lipophorin in the insect wound reaction: During
late coagulation low-density lipophorin including apolipophorin III subunits possibly
associates with lipids in the clot. In the immediate phase this may inhibit haemocyte
spreading and block phenoloxidase activity, thereby preventing an over-activation of the
immune system. Simultaneously the LDLp complex probably also promotes rapid LPS
detoxification, production of reactive oxygen species and phagocytosis of bacteria and
apoptotic cells in the coagulum.  As a secondary result of LDLp formation, gene
induction might also lead to expression of antimicrobial peptides at later time points.
It is fascinating to note that the presented model for possible immune functions of
lipophorin is similar to the situation in vertebrates: Mammalian lipoproteins are
important not only for lipid transport, but are also involved in the regulation of clotting:
Low-density lipoprotein (LDL) activates platelets, while high-density lipoprotein
(HDL) blocks platelet aggregation, even in this case by interaction with lipids
(Rosenson & Lowe, 1998). In a pathological defect lipoprotein (a) is deposited on blood
vessel walls by transglutaminase (Borth et al., 1991). In addition LDL enhances the
phagocytotic activity of macrophages (Carvalho et al., 2002) and stimulates release of
nitric oxide from platelets (Riddell et al., 1997). LDL uptake elevates cytokine
production in vertebrate macrophages and T-cells (Tedgui & Bernard, 1994). The
oxidation state of LDL and HDL can influence clotting intensity as well (Mertens &
Holvoet, 2001).
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The fact that haemolymph from domino mutants of Drosophila failed to aggregate the
beads (Figure 22) suggests a major contribution of haemocytes to coagulation.
Hemolectin and transglutaminase are originally cellular proteins and become localised
at the wound sites by release from degranulating or rupturing haemocytes. Furthermore
cells may act as effective “filling material” in the clot and add mechanical strength to it.
In later steps of clotting the large flattened lamellocytes of D. melanogaster possibly
play an essential role by attaching to RGD-containing clot proteins which might activate
integrin-mediated immune responses.
The pull-out assay led to the first molecular description of proteins involved in
Drosophila haemolymph coagulation and the protein pattern is clearly different from
the total haemolymph proteins (Figure 23). A refined proteomics approach allowed the
identification of additional putative clotting factors (Karlsson et al., unpublished
results). It remains to be clarified if the less abundant proteins in the coagulum reflect a
functional contribution to the clotting process or if they might be caught in the clot as
“filling substance” without being crucial for haemolymph coagulation. A disadvantage
with the pull-out assay is that it is impossible to conclude from the bound protein
amount to the in vivo situation. The harsh washing conditions including detergents
applied in the pull-out may remove weakly bound proteins, which thus escape detection.
Clotting factors might aggregate so quickly in the haemolymph, that they do not get in
contact with the beads. Alternatively proteins may be cross-linked so strongly that they
cannot be recovered from the beads by denaturation in sample loading buffer. Similarly
some putative clot proteins with low abundance in the insect may be missed by the
assay, though they still might have a significant impact on the reaction. In addition the
amount bound of a certain protein cannot be compared easily between different
samples: A weaker band could be due to a lower haemolymph level, but might also be
explained by stronger cross-linking in the haemolymph competing with the bead
contact. A significant difference in the clot protein quantity of a mutant Drosophila
stock or in changed buffer conditions might well represent an indirect effect on the
physiology not directly related to clotting. In summary the pull-out assay is an efficient
approach to isolate the haemolymph clot and even allows quick and inexpensive initial
screening for clotting defects in D. melanogaster. However biological roles of putative
coagulation factors have to be addressed using additional functional assays.
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4.5   Comparison of clotting proteins in Galleria and Drosophila
Several of the identified proteins associated with a haemolymph clot in G. mellonella
and D. melanogaster share similarities. Arylphorins were found in the coagulum of both
Galleria (gallysin) and Drosophila (lsp1c and fbp1). Similarly, lipophorin was present
in clot preparations from both species. These protein belong to the most abundant
haemolymph compounds and might thus be used for quick and efficient association at
the wound site. In addition, lipophorin might interact with exposed phospholipids at the
injury and aid in immune activation (see chapter 4.4). Also phenoloxidases were
identified as integral constituents of haemolymph clots in both Galleria and Drosophila.
It may be assumed that the processes clotting and melanisation are connected to each
other by localised binding of phenoloxidases to the clot, which would prevent
intrahaemocoelic enzymatic activity.
Nevertheless, it may seem surprising that most of the clot-associated proteins differ in
both species. This may be explained in several ways: It is likely that many clotting
substrates in fact are species-specific, simply because the required features for quick
protein aggregation are so easy to acquire throughout evolution. This hypothesis might
be confirmed by the alpha-crystallin like protein from Galleria and the Drosophila gene
product of CG 15825. Alternatively, the different methods used (production of the anti-
clot antiserum in G. mellonella and the bead assay followed by mass spectrometry
analysis in D. melanogaster) may favour or prevent the detection of certain proteins:
The clot used for production of the Galleria antiserum was formed in vitro by a cell-free
haemolymph sample (Li et al., 2002). Therefore cellular coagulogens of G. mellonella
may be missed by this antibody, while the Drosophila clot formed in the pull-out assay
was allowed to form during approximately 20 min in the presence of haemocytes.
However, also the pull-out assay might miss some clotting factors: The anti-clot
antiserum may even identify clot components cross-linked by transglutaminase or
phenoloxidase activity, these may be so strongly bound to the beads of the pull-out
assay that they cannot be removed from them prior to gel electrophoresis and might thus
not be recognised as Drosophila coagulation proteins.
Finally I would like to address the question why hemolectin, which is obviously
important for Drosophila haemolymph clotting, is not represented with a homologous
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protein identified in the Galleria coagulum. Genes with similarity to Drosophila
hemolectin (Goto et al., 2001) exist not only in the related lepidopteran species B. mori
(Kotani et al., 1995) and M. sexta (Scholz, Dissertation 2002), but also in the recently
completed honey-bee genome (gene accession number “XP_395067”,
http://www.ncbi.nhlm.nih.gov). Therefore it appears valid to assume that a hemolectin
homologue is present in Galleria as well. A protein with a molecular weight similar to
hemolectin is a major component of the Galleria clot and its binding requires calcium
(Li et al., 2002, Figure 3A). If this putative “Galleria hemocytin/hemolectin” is
involved in early steps of haemolymph clotting, it might be quickly covered by
interacting factors, rendering it inaccessible to antibody recognition. According to this
assumption the putative Galleria hemolectin homologue may have been present in the
in vitro clot, but not be recognisable by the anti-clot antiserum.
4.6 Regulation of haemolymph coagulation – preliminary results
I tested several mutants of known immune genes (for example spätzle, Toll and
necrotic) with the pull-out assay. No obvious qualitative differences concerning bead
aggregation and bead-associated proteins were observed in any of these cases (data not
shown). This is not too surprising, since activation of clotting should be quick and
therefore probably does not involve molecules implied in gene induction. The actual
clot proteins and enzymes are rather expected to be constitutively present in the
haemolymph or stored in and released from haemocyte granules. Although a wound-
induced induction of hemolectin had been reported (Goto et al., 2001), the re-
investigation described in the present study (Figure 28) led to contrary results. At all
included time points (1, 6, 12 and 24 h) after poking no significant up-regulation of
hemolectin as described by Goto et al. (2001) had occurred, although the same primer
sequences were used in both studies. Several explanations can be given for this
discrepancy: It is quite difficult to normalise the wound size of poked larvae and the
resulting effect on transcriptional regulation. Therefore a comparably strong poking
intensity might have led to an effective depletion of hemolectin resulting in a strong
induction in the work by Goto et al., while this process was delayed or absent in the
larvae used in the present study. Furthermore it remains to be shown, in which time
4   Discussion
_______________________________________________________________________
91
window hemolectin is induced. It could be assumed that if there is an induction of
hemolectin transcription, this does probably not occur during the first hours after poking
and can thus be considered a haemostatic regulation of haemolymph levels.
In an extensive study the effect of several vertebrate blood clotting inhibitors on the
morphological appearance of insect haemolymph coagulation has been tested (Grégoire,
1953). An important side result of this investigation is the observation that use of
different surfaces like e. g. hydrophobic and non-adhesive material or coated glass
slides did not have any impact on clot formation. Inhibitory effects of some of the tested
chemicals should be interpreted carefully, since they caused damage of cellular
structures in general. Furthermore clotting may still occur at wound sites in vivo as well
as at the edges of a sample haemolymph drop or around an incorporated particle even in
the presence of inhibitory substances, due to the enormous speed of the reaction (Beard,
1950 and personal observation). Nevertheless, some of the tested chemicals
significantly reduced coagulation in relatively low concentrations. These compounds
included reducing agents, chelators of calcium ions and organic esters of sulphuric acid.
Since the morphological appearance of haemolymph clots is highly variable (Grégoire,
1953), it is difficult to standardise these results.
I aimed to test the effect of putative coagulation inhibitors on the protein composition
of the clot retrieved with the pull-out assay, which is shown in Figure 29. In general
calcium requirement for the clotting process seems to be a common feature conserved
from invertebrates to vertebrates. This is also supported by the effect of calcium
ionophores on microparticle formation (Figure 11). Similarly even Galleria
haemolymph incubated in a buffer excluding calcium and including EDTA showed a
less extensive cross-linking reaction leading to lower levels of high molecular weight
complexes (Li et al., 2002). Therefore reaction buffers lacking calcium and including
EDTA may be used to inhibit coagulation in vitro. Another compound with a clear
inhibiting effect on insect haemolymph clotting is the antioxidant ascorbic acid (Figure
29 and Gawa Bidla, unpublished results). It was demonstrated earlier that the
aminophospholipid translocase inhibitor and vertebrate anticoagulant suramin also
obstructs insect haemolymph coagulation (Grégoire, 1953). Thus an involvement of
inner leaflet phospholipids in initiation of the clotting process seems likely in insects as
in vertebrates and horseshoe crabs (Nakamura et al., 1998). Preliminary results from
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D. melanogaster and G. mellonella also point towards an activation of melanisation
through phosphatidylserine exposure (Gawa Bidla, unpublished results). In vertebrates
vWF stimulates phosphatidylserine exposure on platelets (Briede et al., 2003). It is
tempting to speculate on a similar regulating mechanism for hemolectin as an initial
regulator molecule for clotting. A localised higher concentration of activating factors or
the cross-linking enzymes might represent a way to restrict coagulation to the wound
site. Hemolectin as a large protein with many accessible interaction domains may
furthermore serve a function as a reaction platform for other clotting factors and bring
interacting molecules into close proximity.
Presently it is not yet possible to organise the different clotting proteins of insects into
an array suggesting a regulation pathway. Another question concerns the biochemical
nature of the regulation mechanisms that check coagulation in a temporal and spatial
manner to prevent over-activation of the reaction. One theoretical possibility is the
separation of a cellular and a plasma coagulogen, as proposed by Bohn (1986). An
alternative explanation could be the presence of inactive pro-forms of the proteins that
undergo proteolytic cleavage or conformational change during the initiation of clotting.
As described earlier, proteolytic cascades regulated by protease inhibitors are
employed by vertebrates and horseshoe crabs, while no such regulation has been found
in crustaceans so far. Proteases involved in the different cascades might have formed
through quick evolution including domain switching of protease domains (see chapter
4.7). Although there is no clear experimental evidence for insects, a proteolytic
activation of insect clotting has been repeatedly assumed (Hoffmann & Reichhart, 2002,
Tzou et al., 2002), probably because regulation of the prophenoloxidase cascade by
serine proteases is already well accepted. Evidence for the general importance of
proteases is the large number of serine protease genes in the Drosophila genome (Tzou
et al., 2002). Activation of clotting by the serine protease scolexin has been proposed
for M. sexta (Finnerty et al., 1999). The data collected during the present study did not
lead to a clear conclusion about a possible role for proteases in Drosophila haemolymph
coagulation. The pull-out assay was performed in the presence of a protease inhibitor
cocktail in additional experiments, which did not lead to qualitative, but possibly some
quantitative changes in the protein binding pattern on the beads (not shown).
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Even if the primary clotting process is independent of proteolytic cleavage, observations
in homozygous serpin-27A mutant larvae point at least towards an influence of
proteases on coagulation. The gene product of serpin-27A negatively limits an
activating enzyme in the prophenoloxidase cascade, thus restricting phenoloxidase
activity to the wound (De Gregorio et al., 2002, Ligoxygakis et al., 2002). It is also
required for establishment of the dorsoventral polarity in Drosophila embryos
(Hashimoto et al., 2003), reminiscent of the dual function of the Toll receptor in
immunity and embryonic development. Since there is an orthologue of serpin-27A in
M. sexta (Zhu et al., 2003), prophenoloxidase regulation by this inhibitor might
represent an evolutionary conserved feature. Haemolymph from homozygous mutant
serpin-27A Drosophila larvae is able to form a clot in vitro, though its morphology is
changed with a more “spread veil” structure compared to wildtype haemolymph
samples (Gawa Bidla, unpublished results). Black cells (Bc) mutants of
D. melanogaster lack haemolymph phenoloxidase activity due to inappropriate
intracellular activation of the enzyme in the crystal cells. Black cells mutants must still
possess cuticular prophenoloxidase and other phenoloxidase-like activities (like for
example laccases), since cuticular sclerotisation is not affected. Wounds in the
integument of Black cells larvae often melanise normally (personal observation).
Binding of haemolymph proteins from single mutations of serpin-27A and Bc to the
beads did not apparently differ from wildtype samples (Figure 30). Surprisingly a
double mutation Black cells / serpin-27A had an impact on the aggregation ability of
the beads (not shown) and led to a lower hemolectin level retrieved from them
(Figure 30). Since the double mutation caused melanotic aggregation of haemocytes
in vivo and an apparently lower haemolymph amount (personal observation),
haemolymph from 30 larvae were used from this stock. Nevertheless the difference in
the hemolectin amount is still visible.  It is probable that proteolytic activation is not a
common feature of all phenoloxidases, since the enzyme CG 8193 found in the pull-out
clot does not possess a conserved cleavage site. If this is the case, the function of these
differently activated phenoloxidases may be not affected in the serpin-27A mutant. In
the double mutant the combined effect of two mutations causing over-reactive and
delocalised phenoloxidase activity might thus result in a deregulated melanisation
phenotype in the haemolymph influencing appearance of the coagulum and possibly
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clot composition. This explanation is supported by microscopical observations of
haemocyte preparations from the Black cells / serpin-27A double mutant, which show
protein aggregation in proximity to haemocytes, but a less abundant fibre network in the
plasma (personal observation). It is difficult to explain the strong effect of a double
mutation Bc/serpin-27A on the amount of hemolectin isolated from the beads, especially
considering the fact that other proteins of the clot seem to be largely unaffected
(Figure 30). It could be hypothesised that this reflects a secondary effect of a generally
reduced number of circulating haemocytes. A hypersensitive reaction at wound sites
and intravascular coagulation caused by circulating clotting factors is avoided in
vertebrates by anticoagulants. The serpin described here might represent such a
regulating factor in insects.
Both phenoloxidase and transglutaminase activity seem to influence hardening of the
clot. Interestingly the single transglutaminase gene in Drosophila displays its highest
similarity not with the factor XIII in vertebrate blood clotting, but with the tissue type
transglutaminase in vertebrates, which amongst others cross-links proteins during
basement membrane formation. Vertebrate parasites express transglutaminases to cross-
link host basement membrane proteins on their surfaces to block vertebrate host
immunity (“molecular mimicry”). This enzymatic activity is crucial for the development
of Plasmodium malariae oocysts (Adini et al., 2001) and parasitic nematodes
(Chandrashekar & Mehta, 2000). While the exact mechanism of this host immune
inhibition is not clear, it is reminiscent of the lipophorin deposition on endoparasitoid
wasp eggs to block a defence reaction in insect hosts (Kinuthia et al., 1999). The cross-
linking activities might therefore not only be important for clot hardening but
furthermore block putative inflammatory characteristics of the coagulum to prevent an
over-activation of the immune system. Vertebrate clotting factor XIII not only has a
function in final cross-linking of fibrin, but also enhances phosphatidylserine exposure
(Bratton, 1993) and stimulates phospholipase A2 (Miele, 2003), thereby playing a key
role in inflammation processes. Phospholipase A2 is also induced in Drosophila after
infections (Irving et al., 2001). As in vertebrates Drosophila transglutaminase may lead
to phosphatidylserine exposure and eicosanoid production. The interplay between
phenoloxidase and transglutaminase activity is not investigated so far. However,
synthetic melanin was recently shown to inhibit a vertebrate transglutaminase in vitro
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(Ikura et al., 2002). The authors of this report claim that the inhibition mechanism is
universal for all transglutaminases. If this regulation should prove to be valid even for
Drosophila and in vivo, phenoloxidase may act at later steps of cross-linking than
transglutaminase, inhibiting inflammatory processes.
From the knowledge available so far I propose the following model for Drosophila
haemolymph clotting: In an initiation phase the wound must be sensed to activate the
clotting process (Figure 32 A). The activation needs to be quick and yet needs to
possess a certain amount of specificity, avoiding haemolymph clotting throughout the
body cavity. So far it can only be speculated, which factors may be required for this
initiation. Since clotting occurs more frequently at the edges of cover slips on a
haemolymph preparation than in the centre of a sample (personal observation), an
involvement of oxygen seems likely. Alternatively released intracellular components
and ruptured membranes of injured tissue as well as exposed negatively charged
phospholipids on apoptotic haemocytes at the wound site might be recognised by
clotting factors or additional haemocytes.
Clotting might then start by degranulating or rupturing haemocytes and probably
primary aggregation of proteins at the wound site (Figure 32 B). In similarity to vWF,
hemolectin has the ability to form large aggregates and may thus represent one of the
primary clotting factors in Drosophila. In addition the hemolectin sequence includes an
autocatalytic cleavage site GDPH (Figure 31), which is conserved in the honey-bee
homologue (gene accession number “XP_395067”, http://www.ncbi.nhlm.nih.gov) and
also present in vertebrate mucins (Lidell et al., 2003). It was described that cleavage of
this motif exposes a new C-terminal end of the mucins, which in turn attaches the
proteins to surfaces and to each other (Lidell et al., 2003). One might speculate that
wound reactions could cause a similar self-activation of hemolectin. However,
vertebrate vWF and B. mori hemocytin lack this autocleavage site and at least for vWF
a conformational change is known to lead to aggregation.
The primary clot may be strengthened and cross-linked by enzymatic activities like
phenoloxidases and transglutaminase released from the haemocytes and thereby locally
concentrated at the wound site (Figure 32 C).
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Finally an unregulated clotting reaction would be detrimental to the organism.
Therefore the process has to be terminated effectively, for which several possible
regulatory mechanisms might be considered (Figure 32 D). An activating signal from
the wound site could be weakened through the forming clot layers or the clotting factors
and enzymes may be used up from the haemolymph. Cross-linking of clotting factors as
an integral part of the reaction might terminate the reaction. However, wound scars are
often not completely melanised (personal observation) and therefore a strict regulation
of the clotting process solely through phenoloxidase activity is probably not the case.
Additional clot-associating proteins may stop the process effectively as well, in analogy
to anticoagulants in the vertebrate system. Possible candidates for such a regulation in
insect haemostasis are annexins and lipophorin, which have been discussed earlier.
Figure 32: A four-step model for haemolymph coagulation in Drosophila
                   (for further explanation see body text)
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4.7   Considerations regarding the evolution of clotting factors
At what point during evolution did the need for coagulation emerge? Which
components did such an ancient clotting system include? Which characteristics of
haemostasis proved to be successful and are present in different organism groups?
Unicellular organisms possess powerful regenerative properties. These are not
specialised for wound healing, but rather part of general cytokinetic processes and
might be similar to actin polymerisation and tightening of “actomyosin purse strings”
around “wounds” in single cells (Henson et al., 2002). Ancient multicellular organisms
with low body pressure probably close wounds simply by contractions. Even in
vertebrates myofibroblasts cause cellular contractions, which play a key role in an initial
compaction of the wounded area (Racine-Samson et al., 1997). The formation of a new
epidermis and spreading of epithelial cells may be an evolutionary old mechanism, as
suggested by Galko & Krasnow (2004). As soon as a primary body cavity developed,
these rather slow reactions were probably not sufficient anymore and injuries had to be
sealed by cellular plugs or coagulated body fluid. The evidence available so far suggests
that the cellular contribution to clot formation is more ancient and conserved than
coagulation of plasma proteins, as pointed out by Aird (2003). In this context it should
be noted once more that blood cell attachment is the primary wound reaction in both
vertebrates and invertebrates and even occurs more immediately than protein
aggregation. In leeches haemocytes and other cells simply stick together to close off
wounds (de Euguileor et al., 1999). Both haemocyte aggregation and degranulation
occur in molluscs, although the matrix around cell clumps is formed much later than
observed in insects, namely 24 h after injury (Franchini & Ottaviani, 2000).
The requirement for quicker clotting of body fluids possibly occurred in connection
with the evolution of the deuterocoele. This included the formation of smaller
haemolymph vessels with higher internal pressure as derivates of the primary body
cavity. At this point a simple protein interaction of a clotting enzyme and one or more
substrates might have been sufficient. It is tempting to hypothesise that an already
existing transglutaminase took over this function. Since the specificity of this enzyme is
not restricted to any conserved sequence motif, the identity of its substrates might be
highly variable as observed (Korayem et al., unpublished results). One could speculate
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that an easy way of acquiring new transglutaminase substrates may be to make use of
pre-existing abundant plasma proteins. General features of coagulation (phospholipids
and microparticle formation, glycoproteins stored in intracellular granules) have
probably been conserved throughout evolution, but the actual proteins incorporated into
the clot seem to have evolved quickly by expansion of certain DNA elements, gene
duplication, exon shuffling and domain switching between proteins.
Sequence comparison between clotting factors of the discussed arthropod groups and
vertebrates does not reveal any orthologues except transglutaminase, which
participates in cross-linking of the clot in vertebrates (Griffin et al., 2002, Jiang &
Doolittle, 2003), horseshoe crabs, crustaceans and seemingly as well in insects
(Korayem et al., unpublished results). Interestingly cross-linking of amino-groups of the
plasma coagulogen with carboxamide groups of the haemocyte coagulogen of a
cockroach by a transglutaminase-like activity has been described earlier (Ferstl et al.,
1989). However, one has to keep in mind that the Drosophila genome includes only one
transglutaminase gene, but eight genes are present in the human genome (Lorand &
Graham, 2003). This suggests that the vertebrate clotting factor XIII has specialised to
perform its action in blood clotting, while the invertebrate enzymes probably fulfil
various physiological functions. Prophenoloxidases are present in insects and
crustaceans and even the related hemocyanins of crustaceans, horseshoe crabs and a
spider (Decker & Rinke, 1998) possess an intrinsic phenoloxidase activity. Hence it is
possible, that in addition to transglutaminases phenoloxidases evolved to provide an
alternative cross-linking activity in arthropod haemolymph.
Many vertebrate vascular proteins like vWF, fibronectin, vitronectin and fibrinogen
have no orthologues in Drosophila, probably due to specialised requirements of the
closed circulatory system of vertebrates (Hynes & Zhao, 2000). Other proteins involved
in clotting in the reviewed organism groups share conserved sequence stretches like
serine protease or vWF domains, but cannot be considered orthologues. Nevertheless, a
conservation of all domains of a certain protein might not even be required for effective
clotting. New transglutaminase substrates may easily emerge from an ancestral protein
by insertion of glutamine- and lysine-rich patterns. The crayfish clotting protein,
which is similar to some insects’ female-specific vitellogenins, could be regarded a
good example for this model. In addition to vitellogenin-like sequence stretches
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(including vWF D-domains) the crustacean clotting protein contains lysine- and
glutamine-rich segments. Although not regarded a clotting factor so far, a glutamine-
rich “early stage encapsulation protein” was identified in the beetle Tenebrio molitor
(Cho et al., 1999) and is a good candidate for a transglutaminase substrate. In the same
insect species a vitellogenin-like protein with high glutamine content enhances
phenoloxidase activity (Lee et al., 2000). Interestingly, in addition to its role as a yolk
protein precursor vitellogenin was also proposed to be a clotting protein in sea urchins
(Cervello et al., 1994). Thus it cannot be excluded that vitellogenins may have a
conserved function in the coagulation process due to intrinsic aggregation properties. In
crayfish an a2-macroglobulin is linked to the clot by transglutaminase and regulates
protease activity at the wound site (Hall & Söderhäll, 1994). Even the amino acid
sequence of this protein includes numerous exposed lysine and glutamine residues. A
protein with high similarity to a2-macroglobulin is present in Drosophila as well
(CG 7052) and might fulfil a similar functions, in case it proves to be an integral part of
the coagulum.
Proteins suitable for clotting frequently form large multimers, enhancing their “sticky”
character (Furlan, 2002). Sequences with similarity to the vWF D-domain are present
in several crayfish coagulogens, the insect proteins hemocytin, hemolectin, lipophorin
as well as vertebrate vWF itself. The vWF D-like domains in vertebrates are flanked by
the CGLCG pattern that facilitates self-catalysed association of vWF (Mayadas &
Wagner, 1992). A truncated GLCG motif was reported to account for the adhesive
properties of the structural glue protein spiggin from a fish (Jones et al., 2001).
Intriguingly five GLCG patterns are present in Drosophila hemolectin (Figure 31) and
all five are conserved in the homologue from Apis mellifera (gene accession number
“XP_395067”, http://www.ncbi.nhlm.nih.gov). Three of these GLCG motifs are present
in the similar proteins of the lepidopteran insects M. sexta and B. mori and the missing
two are situated in the N-terminal end of the Drosophila protein, which is deleted in
these species. The strong conservation of the pattern between three different insect
orders suggests a functional aspect of this motif. A sequence GGLG(Y) with similar
hydrophobic side chains accounts for “sticky” protein properties in mussel byssus
threads, in chorion and other fibrillar proteins of insects as well as in spider dragline silk
(Robson et al., 1993). The tendency of a protein to self-aggregate might be acquired
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easily by mutations and duplications that lead to these sequence motifs. Similarly the
cell adhesion motifs RGD, KGD and LRE of clotting proteins like hemolectin may
have evolved quickly and enhance haemocyte adhesion and immune reactions at the
wound site. Another remarkable feature of hemolectin is the high abundance of 305
cysteine residues exceeding 7,9 % of the complete sequence, compared to an average
1,7 % for all proteins (McCaldon & Argos, 1988). In both hemolectin and vWF
cysteines represent the most abundant amino acid. Cysteine residues have been
proposed to play an important role in vWF multimerisation (Mayadas & Wagner, 1992).
It was calculated that the aggregation ability of vertebrate fibrinogen developed during
approximately 50 million years (Doolittle et al., 1997). Fibrinogen is the only self-
associating and peptide-binding member of an otherwise lectin-like protein family, the
ficolins, including horseshoe crab tachylectin (Kairies et al., 2001) and a number of
fibrinogen-like proteins in Drosophila and Anopheles (Christophides et al., 2002;
Zdobnov et al., 2002). Ficolins consist of a lectin-like and a collagen-like domain and
are involved in the lectin-complement pathway in vertebrates (Fujita, 2002). In the
mosquito Armigeres subalbatus a ficolin-like lectin has recently been implicated in
insect immunity as a pattern recognition molecule (Wang et al., 2004). It might thus be
speculated that the ancestor protein of fibrinogen was rather characterised by its ability
to bind pathogen-associated glycodeterminants. Furthermore it is interesting to note that
casein, responsible for milk clotting, though not phylogenetically related, shares
structural similarity with fibrinogen (Jolles et al., 1978).
Clotting systems of vertebrates and horseshoe crabs independently evolved regulatory
serine protease cascades to ensure a localised reaction. Evolution of the vertebrate
clotting system by relatively recent gene duplication events can be assumed, since lower
chordates (Jiang & Doolittle, 2003) and jawless vertebrates (Davidson et al., 2003) only
possess a simplified cascade. An ancestral protease cascade conserved from
protostomes to deuterostomes as proposed by Krem & Di Cera (2002) is thus unlikely
from today's view. Even in insects evolution of serine proteases was calculated to have
occurred in comparably short geological time periods (Ross et al., 2003). Moreover, the
seemingly evolutionary ancient transglutaminase is the only protein in the vertebrate
cascade that is not a serine protease. The crustacean clotting enzyme is not
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proteolytically activated and whether insect coagulation involves such a regulation
remains to be investigated. Nevertheless, a protease in connection with the insect
prophenoloxidase cascade might regulate both clotting and melanisation, like in
horseshoe crabs (Nagai & Kawabata, 2000).
Arthropods possess an open circulatory system and thus may afford a more extensive
coagulation reaction than vertebrates, which have to keep clotting much more localised
to avoid thromboses. Potentially quicker spreading of microorganisms through the
haemolymph to inner organs might also lead to a stronger need for effective
immobilisation of potential pathogens in arthropod clots (Theopold et al., 2004). Future
studies on coagulation in invertebrates with closed circulatory systems like annelids or
cephalopods would therefore be interesting from an evolutionary point of view. In
general comparative investigations of clotting systems in different insect species might
provide insights into the adaptation of coagulation to a certain environment. A first hint
towards such diversity is given by the different degree of hemolectin conservation in the
genome of the hymenopteran insect Apis mellifera and the dipteran D. melanogaster
compared to the lepidopterans B. mori and M. sexta. It may be an attractive approach to
compare clotting in water-living insects like larvae of dragonflies or Chironomus
tentans with marine but non-insect species like horseshoe crabs and crustaceans to
clarify the requirements of coagulation in an aqueous environment.
Finally some sawfly species (Tenthredinidae, Hymenoptera) have extremely sensitive
integuments and bleed easily as part of an external defence mechanism by toxic
haemolymph compounds (Boéve & Schaffner, 2003). Similarly in some insect orders
“reflex bleeding” is characterised by localised sensitive regions of the integument
(Holloway et al., 1993). It may be assumed that extensive bleeding requires an
especially powerful regulation of the clotting system. In agreement with this theory
easy-bleeding sawfly species suck back haemolymph into the body, heal wounds within
minutes and recover their normal body weight even after repeated haemolymph loss
(Boéve, unpublished results).
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5   Conclusion and Future Perspectives
The aim of this dissertation was to identify and characterise haemolymph clotting
factors in insects. Starting from an almost exclusively morphological description of the
haemolymph coagulum, several putative clot proteins of two insect species, Galleria
mellonella and Drosophila melanogaster have been studied.
A functional involvement of some molecules like Drosophila hemomucin remains
largely unclear and has to be further investigated. The data collected in the present study
underline earlier assumptions of broad biological functions for this protein in immunity
(microparticle formation, pathogen entrapment in the clot) and development (e. g.
possibly trachea formation). Therefore the approach chosen here to knock down
hemomucin in vivo at different developmental time stages and in specific organs by
RNA interference still seems valuable. Since the synthesis of a DNA-construct for
in vivo RNAi of hemomucin was not successful, one can still only speculate about the
specific roles of this protein.
Anti-clot antiserum and pull-out assay independently led to the identification of
lipophorin and prophenoloxidase as clot components. Together with the enzyme
transglutaminase these proteins might represent more conserved constituents in insect
haemolymph coagulation. Even arylphorins of both species, are candidate clotting
factors with analogous counterparts in D. melanogaster and G. mellonella, including the
Galleria gallysin, Drosophila larval serum protein 1c (lsp1c) and fat body protein 1
(fbp1). In contrast, relatively high variability may be expected for transglutaminase
substrates in insects. In agreement with this idea, two species-specific putative
substrates of the enzyme, the a-crystallin-like Galleria protein and the Drosophila
CG 15825 gene product, evolved independently. In summary, the evolution of insect
clotting proteins seems to be characterised by both conservative traits (e. g. vWF D-like
domains, transglutaminase) and quick development of new species-specific elements by
evolutionary tinkering (glutamine residues in e. g. CG 15825; a-crystallin).
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The factors mentioned in the previous paragraph allow only vague assumptions for the
molecular mechanisms underlying the initial steps of haemolymph coagulation. Self-
aggregation of proteins due to certain sequence characteristics such as vWF domains
and glutamine residues, seems to be a likely explanation for quick clot formation.
Drosophila hemolectin is a good candidate for one of the first clot proteins attaching to
a wound and its domain structure suggests interactions with various additional factors.
An in vivo RNAi knock-down of hemolectin led to a clearly affected clotting process.
Drosophila tiggrin and other RGD-containing proteins in the coagulum possibly
represent the link to the haemocytes that assist in closing the wound and stimulate
formation of the new epithelium.
In addition, it becomes increasingly clear that both transglutaminase and phenoloxidase
are involved in later steps of clot formation and strengthen the primary coagulum by
cross-linking of proteins. The interplay of these enzymatic activities is still largely
unexplored and an investigation of their crosstalk may provide insights into their
probably dissimilar roles in clot formation.
Drosophila represents an ideal model organism to study insect haemolymph clotting,
since genetic tools and a huge number of available mutants will facilitate a detailed
description of the coagulation process and its role in the immune system of the fly.
Simultaneously evolutionary questions may rather be successfully addressed by
comparing clotting proteins of different insect orders and species. In the near future the
putative clotting factors described here may be investigated more specifically for their
functions as well as for their interactions with each other. A redundancy of multiple
possible ligands is already commonly accepted for components of the vertebrate
coagulum (Furlan, 2002), but remains to be shown for insects. Similarly many clotting
defects in insects may turn out to be of a quite moderate nature due to overlapping
enzymatic cross-linking activities and possibly even flexibility in the spectrum of
covalently linked substrate proteins.
5   Conclusion and Future Perspectives
_______________________________________________________________________
104
5    Zusammenfassung und Zukunftsperspektiven
Die Identifikation und Charakterisierung von Gerinnungsfaktoren in der Hämolymphe
von Insekten war Ziel der vorliegenden Dissertation. Auf Grundlage einer bisher nahezu
ausschließlich morphologischen Beschreibung des Koagulums wurden mehrere
potentiell an diesem Prozess beteiligte Proteine der beiden Insektenarten Galleria
mellonella und Drosophila melanogaster näher studiert.
Die funktionelle Bedeutung einiger Moleküle wie z. B. Drosophila Hämomucin bleibt
weiterhin weitgehend unklar. Da die Synthese eines DNA-Konstruktes für RNA-
Interferenz in vivo nicht erfolgreich verlief, kann über Funktionen von Hämomucin
weiterhin nur spekuliert werden. Die vorliegenden Daten unterstützen frühere
Annahmen, nach denen dieses Protein an mehreren biologischen Funktionen wie
Immunität (Mikropartikel-Bildung und Demobilisierung von Pathogenen im Clot) und
Entwicklung (z. B. möglicherweise Bildung der Tracheen) beteiligt ist. Daher erscheint
der gewählte Ansatz, die Expression von Hämomucin zu unterschiedlichen
Entwicklungsstadien und in bestimmten Organen zu beeinträchtigen, weiterhin Erfolg
versprechend.
Das Anti-clot-Antiserum und der Pull-out-Assay führten unabhängig voneinander zur
Identifikation von Lipophorin und Phenoloxidase als Bestandteile eines Clots bei den
beiden untersuchten Insektenarten. Zusammen mit Transglutaminase repräsentieren
diese Proteine möglicherweise die konservierten Bestandteile der Hämolymph-
Koagulation in Insekten. Auch Arylphorine sind mögliche Kandidaten für
Gerinnungsfaktoren mit Analogen in unterschiedlichen Insektenarten, identifiziert
wurden u. a. das Galleria Gallysin, sowie Drosophila Larvales Serumprotein 1c (lsp1c)
und Fettkörperprotein 1 (fbp1). Im Gegensatz hierzu kann für Transglutaminase-
Substrate in Insekten eine relativ hohe Variabilität angenommen werden. In
Übereinstimmung mit dieser Ansicht haben sich zwei vermutlich artspezifische
Substrate des Enzyms unabhängig voneinander entwickelt, das den a-Kristallinen
ähnliche Galleria Protein und das Produkt des Drosophila CG 15825-Genes. Die
Evolution von Clotting-Proteinen der Insekten scheint sowohl durch sowohl
konservative Züge (z. B. vWF-D-ähnliche Domänen, Transglutaminase) als auch durch
schnelle Entwicklung neuer artspezifischer Elemente durch hohe Variation innerhalb
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kurzer Zeiträume (Expansion von Glutaminresten in CG 15825 und a-Kristallin)
gekennzeichnet zu sein.
Die zuvor genannten Faktoren erlauben nur erste Annahmen über molekulare
Mechanismen als Grundlage der ersten Schritte in der Hämolymph-Koagulation.
Selbstaggregation von Proteinen aufgrund bestimmter Sequenzmerkmale, wie vWF-
Domänen und Glutaminreste, scheint eine gute Erklärung für die schnelle Bildung eines
Hämolymph-Clots zu sein. Drosophila Hämolektin ist ein guter Kandidat für eines der
primären wund-assoziierten Clotting-Proteine und die Domänenstruktur des Proteins
legt Interaktionen mit zahlreichen weiteren Faktoren nahe. RNA-Interferenz in vivo mit
Hämolektin führte zu einer deutlichen Beeinträchtigung des Koagulationsprozesses.
Drosophila Tiggrin und andere Proteine mit einem RGD-Motiv stellen möglicherweise
die Verbindung des Clots zu den Hämozyten her, welche die Wundheilung fördern und
die Neubildung des Epitheliums anregen.
Es wird zunehmend deutlich, dass Transglutaminase und Phenoloxidase an späteren
Schritten der Clotbildung beteiligt sind und das primäre Koagulum durch
Kreuzvernetzung von Proteinen verstärken. Das Zusammenspiel dieser
Enzymaktivitäten bleibt weitestgehend unerforscht und eine nähere Analyse ihrer
wechselseitigen Regulation wird möglicherweise Aufschluss über ihre vermutlich
unterschiedlichen Rollen im Gerinnungsprozess geben.
Drosophila ist ein viel versprechender Modellorganismus für die Studie der
Hämolymphgerinnung in Insekten, da genetische Methoden und eine große Anzahl
verfügbarer Mutanten eine detaillierte Untersuchung des Gerinnungsprozesses und
seiner Rolle im Immunsystem der Fliege ermöglichen. Durch weitere Arbeiten werden
den hier beschriebenen Faktoren spezifischere Funktionen zugewiesen werden und ihre
Interaktionen untereinander analysiert werden können. In Übereinstimmung mit dem
hier präsentierten Konzept könnten viele Gerinnungsstörungen in Insekten aufgrund von
leicht überlappenden Kreuzvernetzungsaktivitäten und möglicherweise ebenfalls
Flexibilität ihrer Substrate von eher gemäßigter Natur sein. Eine Redundanz der
vielfältigen möglichen Liganden ist für Bestandteile des Vertebraten-Koagulums bereits
akzeptiert (Furlan, 2002).
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